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 Primary non-adherence (PNA) to bisphosphonate medications has been recently 
identified to be as high as 30% in patients with osteoporosis or who are at risk for hip 
fracture.  It is known that taking a bisphosphonate is the main course of defense in 
lowering patient risk and decreasing the hip fracture rate by 50%.  However, if patients 
do not take their medication, they will not receive the benefit of fracture risk reduction 
that comes with it.  This paper explored the testing and implementation of a protocol 
designed to improve the PNA rate and thus improve patient outcomes.  This protocol 
used evidenced-based information that improved the provider-patient relationship 
through a telephone outreach protocol aided by a computer system that identified patients 
who had not picked up their medications from the pharmacy.  The nurse practitioner (NP) 
coordinator targeted each patient and then worked the list of patients at risk until all 
patients had been contacted.  The goal was to lower the PNA rate by 20% by targeting 
those patients who had not picked up their medications and by changing their behavior to 
develop an intention to pick up and take their bisphosphonate medication.  This goal was 
reached as the PNA rate was reduced to 3.2%, although it might have been a combination of 
contributing factors that led to the decrease in rate and not the telephone outreach alone.  The 
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protocol was successful and was accepted into practice to be replicated throughout all of the 
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Statement and Background of the Problem 
 Major advancements in the pharmaceutical management of osteoporosis have 
contributed to drastic reductions in osteoporosis and related fractures.  Therapeutic results 
of medication treatment for osteoporosis can reduce the risk of hip fracture by 47% 
(Ensrud et al., 1997).  The primary treatment of choice for osteoporosis is a class of 
medications called bisphosphonates.  Evidence has shown that patients could have up to a 
50% reduction in their fracture risk if this medication is taken properly (Black et al., 
2000).  The impact of osteoporosis related fractures is significant in terms of poor 
outcomes for the patient as well as being tremendously costly to the healthcare system.  
Medication adherence is essential for reducing morbidity and mortality in patients with or 
at risk for osteoporosis.  Accomplishing medication adherence requires a system of care 
that addresses the individual needs of patients with osteoporosis and provides a method 
for tracking patient data through information technology to identify non-adherence.  
Combining these into a model of care that provides strategies targeting adherence at both 
the individual and systems levels is needed to reduce osteoporosis-related fractures with 
decreased morbidity and mortality in this population.  While strategies are needed at both 
levels to positively impact outcomes of patients with osteoporosis, efforts to accomplish 
this have met with limited success.  
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Management of osteoporosis, as with any chronic disease, is based on the ability 
of health care providers to (a) identify patients at risk for fractures and (b) implement 
evidence-based treatment regimens that will lead to improved patient outcomes, thereby 
reducing morbidity and mortality.  Improved patient outcomes can only occur if patients 
adhere to treatment.  While adherence to treatment can occur at many levels, primary 
non-adherence (PNA) occurs when patients do not pick up their prescriptions within 60 
days of receiving the prescription (Reynolds et al., 2013).  Utilizing information 
technology at the system level to identify those patients who are non-adherent in 
obtaining their medication is one method of alleviating non-adherence and potentially 
impacting outcomes.   
This project focused on answering the following research question: 
Q1 Will a telephone outreach protocol based on the theory of planned  
 behavior (TPB) be effective in lowering the primary non-adherence rate  
 (PNA) to bisphosphonate medication by 20% in a large Health  
 Maintenance Organization (HMO)? 
 
Thus, a protocol designed to increase patient adherence in taking medications was 
implemented and evaluated in a practice setting.  The project included data analysis to 
monitor the activities of patients who had a new prescription for a bisphosphonate and 
whether or not they picked the prescription up from the pharmacy within 60 days.  The  
project investigated whether a protocol that included individual nurse practitioner (NP) 
and system strategies could impact primary non-adherence in patients at risk for or who 








Population/Intervention/Comparison/Outcome/Time (PICOT) is the method used 
in addressing clinical questions related to PNA.  According to Melnyk and Fineout-
Overholt (2011), the components of a PICOT question include patient population, 
intervention, outcome, and timeline to goal completion.  The population for this project 
included men and women over the age of 55 years with primary non-adherence to 
bisphosphonate medication.  The PICOT question answered in this paper was as follows: 
Will the implementation of a practice protocol impact patient primary non-adherence 
(PNA) within 60 days of a new bisphosphonate prescription?  As part of an osteoporosis 
disease management program, NP specialists in osteoporosis disease management 
utilized a protocol that focused on interventions to address and improve the rate of PNA. 
Background and Significance of the Problem 
 This section begins with a brief description and definition of terms unique to and 
used consistently throughout this paper.   
Definitions 
 The National Osteoporosis Foundation (NOF; 2013b) defines osteoporosis as a 
disease characterized by low bone mass and structural deterioration of bone tissue, 
leading to bone fragility and an increased risk of fractures, especially of the hip.  
Osteoporosis is known as a silent disease because bone loss can occur without symptoms 
until a fracture event occurs, making the condition more challenging to prevent and treat 
(NOF, 2013a).  To date, bisphosphonates are proven to be the best medication to treat 
osteoporosis and prevent subsequent fractures (Black et al., 2000). 
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 Primary non-adherence (PNA) of a bisphosphonate occurs when patients do not 
retrieve their new prescription from the pharmacy within 60 days of the date of the 
prescription.  This is also referred to as non-fulfillment.  Secondary non- adherence 
(SNA) describes non-persistence of a medication and occurs when the patient fails to 
refill their medication from the pharmacy after it was initially filled.  This definition of 
secondary non-adherence was included because it is important to understand both of the 
concepts of primary and secondary non-adherence; only PNA was followed for the 
purpose of this paper.   
 The Knowledge Builder Tool is an information technology (IT) tool embedded 
into the electronic medical record (EMR) that assists the nurse practitioner (NP) in 
identifying patients who are not picking up their bisphosphonate medications from the 
pharmacy.  The NP then monitors the treatment to meet program hip fracture reduction 
goals based on national guidelines established by the National Osteoporosis Foundation 
(2013a).  
Statement of the Problem 
Each year in the United States, two million people have an osteoporosis-related 
fracture.  Of these fractures, 300,000 are hip fractures--the most serious of all fractures. 
Primary non-adherence is a major problem in the treatment of patients with osteoporosis.  
Reynolds et al. (2013) stated that 29.5% of patients in a large health care organization 
who were prescribed a bisphosphonate for osteoporosis did not pick up the medication, 
take it, or gain any benefit from it.  Other authors have also shown both PNA and SNA to 
be a problem in the treatment of osteoporosis; this is discussed further in the literature 
review section of this paper.   
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In clinical trials, the use of bisphosphonate treatment has led to a 50% reduction 
in hip fractures (Black et al., 2000).  When not taken correctly, the rate of hip fracture 
increases (Silverman & Gold 2008; Siris et al., 2006).  No intervention other than 
medication adherence has shown this level of success in hip fracture reduction (Siris et 
al., 2006).  Solutions to addressing this barrier are needed to improve treatment rates and 
patient outcomes.  Although clinical and evidence-based guidelines are available to guide 
treatment, high rates of fractures continue, perhaps due to difficulties in primary non-
adherence of patients who have been prescribed bisphosphonate anti-osteoporosis 
medications.   
The significance of PNA spans three levels: the individual patient, the provider, 
and the system.  All three contribute differently to the outcome of PNA and adherence to 
bisphosphonate medications.  Even though health care providers have access to clinical 
care guidelines, there is no assurance they are followed in managing care of patients.  
Historically, published guidelines alone have generally been ineffective in changing 
provider behavior (Grol & Grimshaw, 2003).  In fact, many factors related to knowledge, 
attitudes, and behaviors contribute to a stagnation in implementation of guidelines. 
Cabana et al. (1999) described six barriers: (a) lack of awareness or familiarity with the 
desired change, (b) disagreement with specific guidelines or guidelines in general, (c) 
doubt that following the guideline will lead to desired outcomes, (d) an inability to 
overcome existing practice habits, (e) patient factors such as preferences, and (f) 
environmental factors such as lack of time or resources.   
 Problem at patient level.  Even when there is a system in place for early 
identification and treatment of patients at risk for a hip fracture, if the patient does not 
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pick the medication up from the pharmacy, they will not benefit from the medication's 
fracture reducing action (Silverman, Schousboe, & Gold, 2011).  Silverman et al. (2011) 
identified that patients are not always truthful when asked to self-report the reasons for 
not picking up or taking their medications.  Often times, they report that they simply 
forgot.  It is also known that patient decisions to take or not to take medications might be 
transient and could change with time (Sale et al, 2011).  Patients who do not pick up their 
medications from the pharmacy have made a conscious choice not to do so for many 
different reasons (Silverman et al., 2011).   
 Problem at provider level.  The provider has a responsibility in PNA as well as 
the patient and the system itself.  Lack of communication on the part of the provider 
regarding the diagnosis and the need for medication contributes to non-adherence.  If a 
patient is prescribed a bisphosphonate and the provider does not actually diagnose the 
patient with osteoporosis by dual energy X-ray absorptiometry (DXA) or other means 
and does not discuss the diagnosis with the patient, this decreases the likelihood the 
patient will actually take the medication (Giangregorio et al., 2008).  Without a diagnosis 
or discussion about his/her individual fracture risk and the importance of the medication, 
the patient may not be aware of the necessity to take the medication (Giangregorio et al., 
2008).  Since osteoporosis is usually asymptomatic until the fracture event, the patient is 
less likely to take the medication; more likely, he/she will take a medication to relieve 
uncomfortable symptoms (Giangregorio et al., 2008).  Without open communication 
between the provider and the patient and a mutual agreement and awareness that the 
patient needs to take a medication, the likelihood for PNA is increased (Giangregorio et 
al., 2008).  These authors found that healthcare providers might contribute to the problem 
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of non-adherence through poor communication and lack of making and discussing the 
actual diagnosis with the patient.  
 Problem at system level.  Calls to action by professionals in the field have 
described and advocated for effective nurse practitioner-led models of care to improve 
the care and treatment of osteoporosis and prevention of related hip fractures (Eiseman et 
al., 2012; Marsh et al., 2011).  Addition of the electronic medical record (EMR) and 
information technology tools are solutions to meet focused goals and more efficiently and 
effectively remedy this problem (Marsh et al., 2011).  Marsh et al. (2011) used criteria 
composed of 13 parameters, called the best practice framework and global campaign, 
which outlined the qualities a successful fracture liaison service (FLS) program must 
possess.  According to the Centers for Disease Control (CDC; Crum, 2012), it is essential 
that disease management programs adopt more information technology decision support 
capabilities.  These programs need to incorporate effective systems-based, preventive 
healthcare strategies that will improve the quality and quantity of care needed to meet the 
demands of a growing population.  
 Healthcare delivery systems of the near future will need to expand their capacity 
to care for the growing needs of a diverse, chronically ill, and aging population (Crum, 
2012).  These systems will need to consider the needs of the patient as a member of the 
healthcare team.  If the patient is not a member of the team, he/she cannot be involved in 
understanding the importance of taking the needed medications (Giangregorio et al., 
2008).  The patient’s desire to cooperate is essential if program goals are to be met.  
 The computer can assist by bringing together the responsibility of the patient, 
provider, and the system in the role of improving PNA because it can be used as a tool 
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that can help with improving compliance through early identification of patients with 
PNA and assisting the NP provider to contact the patient to intervene.  Early 
identification and access to pharmacy information can help the NP coordinate the care of 
difficult patients.  Management of PNA by hand is nearly impossible to achieve in a 
paper-based system (Che, Ettinger, Johnston, Pressman, & Liang, 2005; Cheetham et al., 
2013; Kates, O’Malley, Friedman, & Mendelson, 2012).  Improving access to 
communication with the prescriber and pharmacy has lowered the rate of non-adherence 
to medications (Kates et al., 2012).  The computer is the key to accomplishing this.  
Without a system in place, access to information and communication is less likely to be 
effective. 
Other barriers to implementing new practice tools or evidenced-based guidelines 
also need to be addressed.  Primary non-adherence is a major barrier in improving 
outcomes of patients at risk for or diagnosed with osteoporosis (Silverman et al., 2011). 
Methods to address this barrier need to include individual interventions targeting the 
individual patients as well as changes in provider behavior, healthcare models, and 
systems.  Strategies to address PNA should focus on the use of information technology 
tools and electronic medical records to measure the effectiveness of these strategies.  
These strategies can assist the provider in easily accessing guidelines and patient and 
pharmacy information (Che et al., 2005; Cheetham et al., 2013). 
National Statistics 
 Worldwide, osteoporosis causes more than 8.9 million fractures annually, 
resulting in an osteoporotic fracture every three seconds (NOF, 2013b).  In spite of the 
fact that hip fractures are preventable in patients with osteoporosis and acceptable 
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treatment and prevention guidelines have been established, medical costs from fractures 
continue to rise.  Experts in the field agree that total medical costs from fractures will rise 
by almost 50% to $25.3 billion in 2025 (Burge et al., 2007).  Osteoporosis continues to be 
under diagnosed and under treated.  Only one-third of American women and fewer men 
with osteoporosis ever receive treatment (Agency for Healthcare Research and Quality 
[AHRQ], 2014; Eiseman et al., 2012; Gallagher, Grelig, & Comite, 2002; Marsh et al., 
2011; Solomon, Finkelstein, Katz, Mogun, & Avorn, 2003; Solomon, Patrick, Schousboe, 
& Losina, 2014).  Patient adherence is very important if goals of fracture reduction are to 
be met.  Brown and Busell (2011) stated that the number of patients who are non-
adherent in taking their medications overall may be as high as 50%, which outlines a very 
clinically significant problem.  One out of every two women and one in four men over 50 
will have an osteoporosis-related fracture in their lifetime (National Institutes of Health 
Osteoporosis and Related Bone Diseases-National Resource Center [NIH], 2005).  
According to the National Institutes of Health (2005), osteoporosis and related bone 
diseases are responsible for more than two million fractures annually.  As a result, the 
National Bone Health Alliance (NBHA; 2013) has launched a campaign to increase 
fracture awareness to the public (NOF, 2013b; NBHA, 2013).  Hip fractures are the most 
devastating of all fractures; 25% of those who suffer from a hip fracture will die within 
one year.  Additionally, hip fractures are associated with a 2.5 fold increased risk of 
future fractures (NBHA, 2013; NIH, 2005).  
 Cooperation and proactive behavior amongst medical professionals is essential in 
decreasing osteoporosis and subsequent hip fractures.  Despite the recommendations and 
support for osteoporosis disease management programs by the Centers for Disease 
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Control (2010), National Osteoporosis Foundation (2013a), and Agency for Health 
Research and Quality (2014), osteoporosis screening and treatment rates remain low 
worldwide.  Gallagher et al. (2002) found that only 12–34% of women at high risk for 
fracture in a managed care network were screened for osteoporosis.  Jachna and Forbes-
Thompson (2005) cited that less than 50% of 1,200 adults aged 60 years or older 
surveyed in the northeastern United States reported that their doctor even recommended 
osteoporosis screening.   
 Developing methods for prevention and treatment of osteoporosis are critical to 
ensuring better detection and treatment of this disease before major complications occur.  
Heaney (2003) found there was inadequate participation of doctors in the proper 
screening, prevention, and treatment of patients with fractures.  Patients were not 
receiving a DXA scan or treatment post fracture.  Patients did not take their medications 
if they were not told they had osteoporosis and did not understand the risks of not taking 
their medications (Giangregorio et al., 2008).  The American Society of Bone and 
Mineral Research has recommended the implementation of more fracture liaison service 
(FLS) programs to remedy this problem of patients not taking their medications (Eisman 
et al., 2012; Reynolds et al., 2013).  Despite the endorsement of many professional 
organizations for FLS-type programs, treatment rates remain low.  Lack of adherence to 
treatment is further compounded by the problem of PNA.  Even those patients who have 
been prescribed treatment are non- adherent in obtaining or taking their medications 
(Reynolds et al., 2013).   
Solomon et al. (2003) reported that roughly four out of five patients in one hospital 
system did not fill a prescription for an osteoporosis medication within six months after their 
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incident fracture.  The problem of PNA is a significant barrier.  Thus, Reynolds et al.’s 
(2013) research was the cornerstone and benchmark for this project, which calls for the 
development and implementation of a tool to decrease the incidence of PNA.  
Financial Impact 
 According to the 2004 U.S. Surgeon General's Report on Bone Health (U.S. 
Department of Health and Human Services) and the National Osteoporosis Foundation 
(2013b), osteoporosis is a major public health threat in the United States and has an 
estimated cost of $18 billion each year (Burge et al., 2007).  The cost of the Medicare 
program alone is projected to increase 50% from 2012 to the year 2020 (Eisman et al., 
2012).  This impacts the capacity of Medicare in financially supporting treatment in lieu 
of dwindling resources.  Based on available evidence, Medicare spending on preventable 
hip fractures has sparked a concern to provide better, more cost-effective care (Eisman et 
al., 2012; Marsh et al., 2011; National Committee for Quality Assurance [NCQA], 2010). 
The majority of the costs of healthcare will be focused on providing services for older 
adults who are at risk of fractures (Mitchell, 2011; NOF, 2013b).  Approximately 20% of 
patients who suffer a fracture due to osteoporosis will experience a repeat fracture in the 
next five years (Solomon et al., 2014).  They represent the highest risk group who would 
benefit from treatment and lead to cost savings.  Furthermore, Solomon et al. (2014) 
calculated a cost analysis for treating fractures versus preventing fractures with the use of 
an FLS program.  They found that the FLS program reduced fractures and calculated that 
significant projected reduced costs would ensue mainly due to early and effective 
bisphosphonate treatment initiation.  They stated that approximately 2.5 million 
osteoporotic fractures occur each year and estimated that if all the post-fracture patients 
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were cared for appropriately, the cost savings might equal as much as $16.7 million.  The 
savings would come largely from patients taking their medications (Newman, Ayoub, 
Starkey, Diehl, & Wood, 2003; Solomon et al., 2014).  According to recent data, the 
generic medication, Alendronate, costs $250 per year while the cost of treating one hip 
fracture is estimated to be $30,000 (CDC, 2010).  This is a reduction from the previously 
reported cost by the Geissinger study (Newman et al., 2003), which showed the cost of 
hip fracture treatment was five times greater than the cost today for an oral 
bisphosphonate.  With the availability of generic Alendronate in 2008, the cost was 
significantly reduced from previously brand named medication prices.  By comparing the 
two costs, the savings are evident and worth implementing (Solomon et al., 2014).  The 
steadily increasing cost of care and the work lost by those affected with osteoporosis and 
fracture add billions more to this figure.  With an aging population, the number of hip 
fractures and related cost expenditures is expected to triple by 2040.  The costliness of 
osteoporosis and other related complications further highlight the need for 
implementation of disease management programs (Burge et al., 2007). 
Theoretical Framework 
 In applying a structured theory to practice, it is important to fully understand and 
integrate applicable concepts, which come from life or clinical experiences (Chinn & 
Kramer, 2010).  According to Solomon et al. (2003), evidence alone is not a motivator in 
changing provider practice or patient behaviors.  Patient compliance and cooperation with 
treatments are essential components to the success of any disease management program 
(Solomon et al., 2003).  To overcome the barriers to change, a comprehensive model that 
incorporates theory and practice is needed.  Information technology tools that focus on 
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improving compliance with medications have the potential to facilitate improvements in 
PNA and close care gaps (Kastner & Straus, 2009).  According to the literature, the PNA 
care gap is not currently being addressed.  A care gap is defined as a treatment or action 
that is not being appropriately applied. 
 Theoretical principles can be used to guide and improve the quality of practice. 
One theory that could accomplish this is the theory of planned behavior (TPB; Ajzen, 
1991).  Theory of planned behavior deals with the link between beliefs and behavior.  
The theory of planned behavior has been applied to studies that deal with attitudes, 
behavioral intentions, and behaviors in different professions such as advertising, public 
relations, and healthcare (Ajzen, 1991).  According to Ajzen (1991), attitudes lead to 
behavioral intentions that then lead to carrying out a behavior.  A person must have the 
intention to act upon it before it becomes a behavior.  The TPB was created to predict 
health behavior at particular points in time, to discover the variables that determine health 
behavior, and to assess their ability to predict it.  The theory adds to the concept of 
behavioral change and control, which began from self-efficacy theory (SET).  Self-
efficacy was proposed by Bandura in 1977 and has a foundation in social cognitive 
theory.  The theory of planned behavior states that attitudes toward behavior, subjective 
norms, and perceived behavioral control, together, shape an individual's behavioral 
intentions and behaviors.  
 Theory of planned behavior provides the basis for understanding patient behavior 
change related to medication adherence.  According to TPB, patients’ attitudes and 
control beliefs (self-efficacy) determine their action regarding adherence (Ajzen, 1991). 
Interventions can be initiated that address patients’ attitudes, control beliefs, and 
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perceived control, leading to changes in intention and behavior (Morisky, 2008).  For 
example, when the NP calls that patient who has not picked up their medication, it is 
believed the telephone call and the NP acting as change agent will help the patient to 
develop a new intention and then a behavioral change will occur.  The way TPB affects 
patient behavior is through the NP acting as change agent implementing the concepts of 
TBP.  The NP has a strong belief in TPB and relays this positive belief in TPB to the 
patient during the telephone call.  The patient is made aware of what is expected of 
him/her by the healthcare provider and the patient gains knowledge of the importance of 
taking the medication.  The patient wants to do what is right—subjective norms, what is 
expected of them by others—social norms, and will act within their physical ability to 
make the change happen—perceived behavioral control. 
 Through TPB, the patient shall act of his/her free will, change the behavior, and 
pick up the medication from the pharmacy.  The laws of social norms, perceived 
behavioral norms, and subjective norms (Ajzen, 1991) will be evidenced by the patient 
changing his/her behavior.  The patient will also have a change to verbalize that it was 
the call that influenced his/her behavior due to the telephone outreach call.  Theory of 
planned behavior uses various beliefs that influence the perceived behavioral control of 
the patient (subjective and social norms).  In this project, a protocol for behavior change 
was based on normative beliefs of the system and subjective norms (beliefs supporting 
adherence of those interacting with patients).  The system provided strong support for 
behavior change through its ability to record, collect, and report data related to 
medication adherence.  Subjective norms were reflected through activities of the NP 
coordinator who acted as the change agent and implemented the protocol supporting the 
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change.  The protocol focused on interventions based on normative beliefs of the system 
and subjective norms of the NP coordinator and other staff.  The effect of the protocol on 
the patient’s control beliefs, perceived control, and ultimately his/her behavior could then 
be measured.  The perceived behavioral control and control beliefs of the patient were 
prerequisites to adopting adherent behaviors related to taking the medication.  Utilizing a 
protocol that incorporated the concepts from TPB and addressed both perceived control 
and the patient’s self-efficacy was necessary for behavior change to occur. 
 According to Fawcett (2005), outcomes can be predicted and measured by using 
an empirical referent.  An empirical referent is defined as a concrete and specific 
instrument, experiment, or procedure used to measure a concept.  In this case, the 
empirical referent was the Knowledge Builder Tool (KBT) computer system.  The NP 
used the KBT to measure the concept of PNA through a telephone outreach program.  
According to Ajzen (1991), behavioral beliefs can determine the likelihood of how 
successful one can be in changing a behavior in order to facilitate adherence of a 
particular behavior.  The stronger the belief that the NP would be effective in changing 
patients’ behavior to pick up their medication from the pharmacy, the greater the 
perceived probability that the new behavior produced a given, desired outcome.  The 
degree of belief about behavior change is directly connected to the favorable or 
unfavorable outcome, also known as belief strength.  One must have the motivation to 
comply with the desired change (Ajzen, 1991).  In this case, the change would be in the 
staff’s belief that when the program was applied to their patients, it would result in the 
desired effect of change in patient behavior to lower PNA.  Prior to this study, there was 
a baseline of 29.5% of patients who did not pick up their medications.  This prior 
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behavior had no influence on the NP until the tool was applied to make change.  The TPB 
has been used successfully to predict and explain a wide range of health behaviors and 
intentions including smoking, drinking, health services utilization, breastfeeding, and 
substance use.   
 The TPB states that behavioral achievement depends on both motivation 
(intention) and ability (behavioral control).  It is distinguished by three types of beliefs: 
behavioral, normative, and control.  The TPB is comprised of six concepts broken down 
into three main areas; together, they represent a person's actual control over his/her own 
behavior.  
 The first of the six concepts is called attitudes--the degree to which a person has a 
favorable or unfavorable evaluation of the behavior of interest.  The second is called 
behavioral intention--the motivational factors that influence a given behavior.  Where 
there is strong intention to perform the behavior, the more likely the behavior will be 
performed.  The third concept is subjective norms--the belief about whether most people 
approve or disapprove of the behavior.  Subjective norms relate to a person's beliefs 
about whether peers and people around them of importance think he or she should engage 
in the given behavior.  Subjective norms were very important to this project because the 
NP knew her actions were being observed so she would do her best to act in a way she 
believed was expected of her by her superiors.  Next are social norms--the customary 
codes of behavior in a group; these might only apply to what the NP believed she should 
be doing in her scope of practice or what she believed should be applied to her tasks in 
order to assist the patient to change his/her behavior and pick up the medication.  Next is 
perceived power--the perceived presence of factors that might facilitate or hinder 
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performance of a behavior.  The NP must work within a framework and has to believe the 
time frame given, the environment, and the nature of the workload are reasonable. 
Perceived power contributes to a person's perceived behavioral control over each of those 
factors.  The NP must believe she has some power over the situation in order to believe 
her action will make a difference.  The last action is perceived behavioral control--a 
person's perception of the ease or difficulty of performing the behavior of interest.  
Perceived behavioral control is related to perceived power over one’s environment.  In 
this project, perceived behavioral control applied to the specific telephone protocol, 
which resulted in the patient exhibiting behavioral control to change his/her behavior and 
pick up his/her medication when previously, prior to the intervention, he/she did not have 
this intention. 
 Constructs of TBP and its application to this project were reduced to three main 
influences that were the focus of this project: behavioral beliefs, normative beliefs, and 
control beliefs.  Behavioral beliefs are beliefs that the actions of the person would result 
in desired change.  Normative beliefs are when the person knows he/she is being watched 
and so will want to perform in an acceptable way.  Control beliefs involve the person’s 
beliefs that he/she has some control over the environment and some control over the 
ability to make change.  These concepts of the NP’s beliefs in the context of the three 
influences of TPB were especially important for this project. 
 The method used to evaluate the program was called the CDC framework for 
program evaluation.  The CDC (1999) framework for program evaluation is a systematic 
approach to ensuring that questions worth significance of the program were addressed; it 
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worked to engage stakeholders, described the program, evaluated the design, gathered 
credible evidence, justified conclusions, and shared lessons learned. 
 In summary, the TPB process flow began with behavioral beliefs, turned into 
normative beliefs, a development of an attitude toward the belief itself, and the person’s 
perceived control that led to the formation of a behavior intention and ultimately the 
action itself.  The person developed his/her own free intention to perform the change 
(Ajzen, 1991).  It was very important that these three concepts be tied together and flow 
in a systematic way in order for them to be effective in changing beliefs, behaviors, and 
outcomes (Ajzen, 1991). 
Literature Review 
 Osteoporosis and subsequent fracture affect millions of people in America and 
worldwide.  Many people who sustain a hip fracture never regain their previous level of 
functioning (Burge et al., 2007; Eisman et al., 2012; Marsh et al., 2011).  Although there 
is unanimous agreement from all major osteoporosis societies around the world that 
fragility fracture is preventable, efforts to date have not resulted in lowering the hip 
fracture rate.  Experts in the literature agreed that a fracture liaison service (FLS) 
program is the most effective approach to fracture prevention.  However, no one to date 
has been able to address all of the barriers to effectively closing persistent care gaps that 
result in increased fracture risk and subsequent fracture (Eisman et al., 2012; Marsh et al., 
2011; Siris et al., 2006).  The most important element of the FLS program for fracture 
prevention is the early identification and treatment of patients at risk for a hip fracture 
with a bisphophonate (Dell, 2011; Siris et al., 2006).  Until recently, the problem of 
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primary non-adherence has not been known.  There is little research to support the 
findings or solutions to PNA (Reynolds et al., 2013). 
Bisphosphonates are the medications of choice for the treatment of osteoporosis 
(Eisman et al., 2012; Marsh et al., 2011; Siris, Boonen, Mitchell, Bilezikian, & 
Silverman, 2012; Siris et al., 2006).  When osteoporosis is diagnosed by dual energy 
absorptiometry (DXA) scan or by fragility fracture, the patient will often suffer a 
subsequent fracture if not treated.  Fifty percent of the time without adequate treatment 
after a fracture, the patient will go on to suffer a second fracture (AHRQ, 2014; Eisman et 
al., 2012; Marsh et al., 2011; NOF, 2013a).  
 The literature stated that it is necessary to use the electronic medical record 
(EMR) and incorporate information technology (IT) such as the Knowledge Builder Tool 
(KBT) to further investigate non-adherence to bisphosphonate medication and the causes 
of it (Dell, 2011).  Patients who do not take their medication cannot receive the fracture 
risk reduction a bisphosphonate provides.  A bisphosphonate has been shown to be the 
best way to reduce fracture risk by 50% (Ensrud et al., 1997). Studies (Burge et al., 2007; 
Eisman et al., 2012; Ensrud et al., 1997; Marsh et al., 2011; Sirris et al., 2006; Solomon 
et al., 2014) supported the early initiation of bisphosphonate treatment in lowering the hip 
fracture rate and lowering the huge economic burden of osteoporotic fractures when the 
problem is not addressed properly and secondary fractures result.  Subsequent fracture 
incidences cause increased care costs due to the severe morbidity and mortality 
associated with fracture.  Without control, this problem and associated costs are predicted 
to increase dramatically in the future (Burge et al., 2007).   
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 Research studies such as one conducted by Marsh and colleagues (2011) and 
articles written by Eisman et al. (2012); Dell, Greene, Schelkun, and Williams (2008); 
Dell, Greene, Anderson, and Williams (2009); and Dell (2011) all added to the body of 
knowledge and provided evidence that has helped to further develop fracture liaison 
service (FLS) programs, care pathways, risk assessment models, and calculators.  These 
authors indicated the importance of early identification and treatment using a dedicated 
NP coordinator and a systems-based approach that includes initiation with a 
bisphosphonate medication as critical to lowering the hip fracture rate.   
 This evidence was the foundation upon which this capstone project was built.  
Morbidity and mortality rates related to hip fracture are high--up to 25% of patients die 
within the first year following a hip fracture.  Less than half of those who survive the hip 
fracture regain their previous level of function (Center, Bliuc, Nguyen, & Eisman, 2007).  
Silverman et al. (2011) and Silverman and Gold (2008) showed that PNA is a major 
problem, resulting in continued hip fracture regardless of other factors.  Implementation 
of an FLS program and the process of continuous quality improvement could identify and 
set new goals to meet fracture reduction goals.  The FLS program uses continuous quality 
improvement and information technology tools to monitor progress and identify new 
problems that need to be addressed (AHRQ, 2014; Dell, 2011); progress is measured and 
monitored by the program NP coordinator through documentation of performance goals 
and outcomes.  This information is shared between medical centers.  Friendly 
competition helps each medical center meet their bench mark and shows how each 
program is progressing (Dell et al. (2009).  The program with a systems approach allows 
for continuous feedback that keeps the program aware of which goals are being met, 
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which measures are not being met, and what might be needed to address the problem or 
make changes (Dell, 2011; Eisman et al., 2012; Marsh et al., 2011; Reynolds et al., 
2013).  Currently, PNA is a major barrier compounding the problem of missed 
opportunities for fracture reduction (Reynolds et al., 2013; Silverman & Gold, 2008).  
The only way to meet fracture reduction goals and see cost savings is through the 
implementation of an FLS program that uses a dedicated program coordinator such as an 
NP (Eiseman et al., 2012; Reynolds et al., 2013; Silverman & Gold, 2008).  
 Reynolds et al. (2013) investigated  the Kaiser Permanente Healthy Bones 
Program (KPHBP) Southern California pharmacy database and reviewed records of 
8,454 women who were prescribed a bisphosphonate treatment for post fracture care. 
Results revealed that 29.5% of the women who had been prescribed medication did not 
pick up the medication for 60 days.  These women fulfilled the criteria for being non-
adherent based on the authors’ definition of PNA.  Reynolds et al.’s study was used as a 
benchmark because it was the only study to date that identified and quantified the 
incidence rate of PNA in bisphosphonate use. 
 Another prospective observational study (Dell, 2011) evaluated the changes of 
osteoporosis disease management in the Kaiser Southern California Health-Maintenance 
Organization (HMO) for the years 2002 to 2006 inclusively.  The Kaiser Permanente 
electronic medical record (EMR) called HealthConnect was used to gather data on anti-
osteoporotic medication prescriptions written, dual x-ray absorptiometry scans (DXA), 
demographic information, and information related to hip and other fragility fractures in 
more than 620,000 patients.  The results revealed that through a team approach using a 
NP champion to provide leadership in a disease management program, the fracture rate 
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was reduced by greater than 40%, saving millions of dollars and preventing hip fracture 
(Dell & Greene, 2010; Dell et al., 2008; Greene & Dell, 2010; Newman et al., 2003).  
 Burge et al. (2007) discussed the impact of the lack of fracture management on 
the skyrocketing costs of fracture care in the United States and world-wide. 
Comparatively, cost savings were demonstrated by using information obtained from 
fracture liaison service (FLS) in the United Kingdom (National Health Service and The 
National Health and Care and Excellence) and the National Institute for Health (NIH) in 
the United States (AHRQ, 2002; Compston, 2010; Mitchell, 2013).  In the United 
Kingdom, The National Health and Care and Excellence (NICE) has demonstrated that 
through the example of the fracture pyramid, FLS type programs could use the cost 
savings gained to pay for future program costs associated with the successful evolution 
and sustainment of the program (Mitchell, 2013).  A pyramid gives a visual depiction of 
how it is possible to use cost savings from the program to pay for other interventions and 
further lower cost (see Figure 1); costs could be distributed to address the top of the 
pyramid and work down to use money saved in highest risk groups to address other 
patients at risk for fragility fracture (Mitchell, 2013).  Hip fractures are the most costly of 
all fractures.  The pyramid was one example of the foundation upon which this capstone 
project was based.  The reason for the development of the telephone outreach program is 
to lower the rate of PNA; a dedicated NP coordinator was able to implement early 
identification of patients at risk for a hip fracture and then initiated and monitored the 
treatment of patients with a bisphosphonate therapy.  This action is the most effective 
method in lowering the hip fracture rate.  Reynolds et al. (2013) identified the rate of 
PNA in this bisphosphonate population; however, no protocols were developed to address 
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how this rate could be lowered.  Improving overall adherence has been noted by several 
researchers (Cook, 2008; Cook, Emiliozzi, & McCabe, 2007; Giangregorio et al., 2008); 
all suggested that the incorporation of a telephone outreach protocol was effective in 
improving patient adherence to medications.  
 
 
Figure 1.  The fracture pyramid (Marsh et al., 2011).  
 
 Kanis, Johnell, Oden, Johansson, and McCloskey (2008) and the World Health 
Organization developed a risk calculator called FRAX, which assists the provider in 
various countries around the world in making cost-effective treatment decisions based on 
a series of questions that reveal the patient’s probability of fracture and whether or not 
treatment is advised (Kanis et al., 2008).  Both the online calculator (FRAX) and the 
fracture reduction pyramid model diagram are examples of tools to help guide cost- 
effective treatment methods that can be used to guide practice (Kanis et al., 2008; 
Mitchell, 2013).  However, the patient must first pick the medication up from the 
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pharmacy in order for any cost-effective models to work as intended (Reynolds et al., 
2013).   
 Nayak, Roberts, and Greenspan (2011) also made comparisons in their study to 
the improvements in the cost of treating patients with a bisphosphonate compared to not 
preventing and treating a costly hip fracture.  They found that oral bisphosphonate 
treatment was estimated to have an adherence rate of 50% and a patient transient habit of 
five year on and off treatment patterns with no official program in place.  Nayak et al. 
(2011) and Sale et al. (2011) found that of the strategies for postmenopausal osteoporosis, 
screening and compliance to treatment were most cost-effective when initiated by age 55 
because the risk of fracture increases with the age of the patient.  Adherence to the 
medication prescribed in this age group is improved especially if the provider discusses 
the diagnosis and importance of the treatment with the patient (Giangregorio et al.,  
2008). 
 Another comprehensive review (Dell & Greene, 2010) of osteoporosis fragility 
fracture prevention focused on cost-effective strategies to decrease fracture risk.  This 
study focused on how to cost-effectively identify, risk stratify, treat, and then track 
patients at risk for osteoporosis and fragility fractures in the KP Healthy Bones Program 
(Greene & Dell, 2010).  The Southern California Kaiser Permanente Healthy Bones 
Program (KPHBP) showed that with the use of a fracture liaison service (FLS) program 
and treatment with a bisphosphonate, four fragility fractures were prevented in every 100 
patients who were treated (Dell et al., 2008).  This information is useful in predicting cost 
savings for a program when it is applied to a large population of patients.  Bogoch et al. 
(2006) found similar cost savings results in their fracture treatment program by using 
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similar techniques of FLS intervention.  Early identification and treatment resulted in 
reduction in the fracture rate--out of every 100 patients treated, six fractures were 
prevented in their large patient population.  
 Dell (2011) confirmed cost savings data gained from using an FLS systematic 
approach to fracture prevention and early bisphosphonate treatment initiation.  Based on 
four to six hip fractures for every 100 patients treated with bisphosphonates, the cost of 
treatment decreased due to the lower cost of generic forms of bisphosphonate 
medications.  Solomon and colleagues (2014) further synthesized this cost savings 
information and determined that the cost of bisphosphonate medication was currently 
$250 per year compared to $507 per year 10 years ago.   
 Original examples of cost savings were seen with the Geissinger Health System 
study (Newman et al., 2003) of their osteoporosis disease management program.  Based 
on results of their study, recommendations were made to increase diagnosis and treatment 
of osteoporosis in a more systematic and organized approach than was being done 
typically in other health centers.  The Geissinger Health System was one of the first 
chronic disease management programs that used clinical practice guidelines in such an 
effective manner to address osteoporosis disease management and to prevent fractures. 
From 1996 (inception of their program) until 2003, the Geissinger Health System  
performed more than 75,000 DXAs and increased their utilization of bisphosphonates. 
Cost savings results were evidenced by a five-year analysis that showed a decrease in the 
hip fracture rate of approximately 40% (Newman et al., 2003).  Although further 
projections of cost savings by Solomon et al. (2014) included the cost of office visits, 
treating side effects, and the cost of buying the medication, the Geissinger Health Study 
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was purely an estimation of the cost of buying the medication.  Professional societies 
such as the American Society for Bone and Mineral Research have supported initiatives 
to employ best practice standards of care such as using a fracture liaison service (FLS) 
coordinator and implementing early treatment with a bisphosphonate (Dell et al., 2008; 
Eisman et al., 2012; Greene & Dell, 2010).   
 Other components in providing cost effective care to specifically close the PNA 
care gap include the addition of an EMR and information technology (IT) tools (Che et 
al., 2005; Cheetham et al., 2013).  The IT and EMR tools have been shown to optimize 
both care provided and outcomes achieved (Che et al., 2005; Cheetham et al., 2013).  The 
EMR is an effective tool in lowering hip fracture rates cost effectively through improved 
record keeping and the facilitation of communication techniques such as telephone 
outreach (Che et al., 2005; Cheetham et al., 2013).  The KBT computer enhances 
communication by providing medical record information in real time for providers to 
access.  The provider has the information readily available to use during phone calls and 
communications with the patient and with other providers as necessary.  The computer 
uses alerts and reminders that can communicate to providers the tasks to be done.  The 
computer is able to automate communications with the patient such as letters that remind 
patients to make follow up appointments.  Without the computer, the provider would 
have to rely on the patient to provide up-to-date historical information or to wait for 
paper charts to arrive, which might not contain current information.  This lack of readily 
available information makes the provider appear unfamiliar with the patient’s case or 
his/her needs (Che et al., 2005; Cheetham et al., 2013).  Computer information 
contributes to the overall body of knowledge by showing that fracture reduction goals can 
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be more easily met by enhancing awareness about chart information, improving 
communication, and tracking of results that cannot be done in a paper-based system (Che 
et al., 2005; Cheetham et al., 2013).  It is important for the provider to be directly familiar 
with the patient’s case, lab results, and diagnosis in order to build rapport and trust with 
the patient.  Lack of current knowledge by the provider during communication with the 
patient might affect the patient–trust relationship (Che et al., 2005). 
Causes of Primary Non-Adherence  
at the Patient Level 
 Factors at the patient level need to be addressed in determining the cause of PNA 
in the literature.  It is important to look at the baseline reasons in the literature of why 
patients have self-reported they did not pick up their medications.  Greenwald et al. 
(2002) used a patient self-reported survey (n = 144) to investigate the reasons patients 
had not picked up their bisphosphonate medications in 30 days.  Similar to Reynolds et 
al. (2013), Greenwald and colleagues found that after 30 days, 37.5% of the patients in 
this study were shown to have PNA.  Although their study did not exactly match 60 days, 
the reasons patients did not pick their medications after 30 or 60 days did not differ 
(Reynolds et al., 2013).  Reynolds et al. looked at increments of time at two weeks, 30 
days, 45 days, and 60 days.  The main reasons for non-adherence in the Greenwald et al. 
(2002) study given by patients were a deficiency in the communication about the 
medication, the lack of understanding regarding the need for the medication, and many 
simply forgot to pick it up from the pharmacy.  Another study by Waalen, Bruning, 
Peters, and Blau (2009) showed that 28.5% of women over 60 years of age (n = 102) did 




 McHorney et al. (2008) and Sale, Beaton, Sujic, and Bogoch (2010) both reported 
common reasons patients gave for not picking up their medications: osteoporosis health 
concerns, drug costs, dosing frequency convenience, and  potential for experiencing side 
effects.  Multivariate analyses conducted by Sale et al. on 1,092 (33%) women showed 
that patients commonly were more adherent if they believed the drug would help them or 
if it would relieve uncomfortable symptoms.  Based on these studies, non-adherence was 
directly connected to patient beliefs; they must believe they need the medication in order 
to relieve symptoms, to improve their outcomes, and if the risk of side effects are 
minimal.  Moreover, Sale et al. stated that reasons for non-adherence were not consistent 
and might even evolve or change with time.  Transient patient beliefs make it especially 
difficult to understand, measure, or to monitor compliance.  Better systems using 
information technology could provide the methods by which behaviors could be 
monitored (Sale et al., 2011).  
 Sale et al. (2011) studied the specific reasons for non-adherence through self-
reports of patients.  They concluded that self- reported questionnaires might not be 
reliable or objective sources of data.  When patients reported that they forgot to pick up 
their medication, they did not want to reveal their real reasons for fear of appearing 
uncooperative (Sale et al., 2011).  Sale et al. further concluded that patients might be 
more truthful with their reporting if there was more open communication between 
prescribers, which would make patients feel more comfortable in disclosing all truthful 
reasons even if against the advice of the medical prescriber.  Through more open 
dialogue, patients might feel less inhibited or judged by healthcare providers and might 
feel more comfortable in being frank with their responses, which might be based on fear 
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of a medication side effect or lack of education.  Both the patients and healthcare team 
must work harder to improve health literacy problems.  More accurate patient responses 
occur if patients are in a more relaxed, non-judgmental environment.  
 Reynolds et al. (2013) and Cheetham et al. (2013) showed that undesirable side 
effects of medications experienced by the patients were found to be more closely 
connected with secondary and not primary non-adherence because those patients with 
secondary non-adherence (SNA) had already previously picked up and started the 
medication and then suffered an undesirable side effect.  Secondary non-adherence 
occurs when patients self-stop the medication and do not refill it again (Cheetham et al., 
2013; Reynolds et al., 2013).   
 McHorney and Spain (2011) conducted a study in which patients self-reported 
reasons why they did not fill their new prescription medications.  The results showed a 
direct association between reported reasons for non-fulfillment (PNA) and non-
persistence (SNA) as compared to their particular chronic disease, which might be 
different and even change at times.  McHorney and Spain further indicated that patients 
were motivated by fear of having a serious health consequence for not taking a needed 
medication.  The patient must believe it is important for them to take their medication 
(McHorney & Spain, 2011).  
 According to Gadkari and McHorney (2010), one in three patients never picks up 
their medications from the pharmacy.  They found the way patients perceived their 
disease condition or their perceived need for the medication, fear of side effects, and 
whether or not the medication would relieve an uncomfortable symptom played a large 
role in whether or not they took the medication.  In their meta-analysis, 79 studies 
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reported pure nonfulfillment rates--59 at the patient level, 20 at the prescription level, and 
six in combination with non-persistence.  The non-adherence rates ranged from 0.5% to 
57.1%.  Three primary reasons for non-adherence were identified: (a) perceived concerns 
about medications, (b) lack of perceived need for medications, and (c) medication 
affordability issues.  In this meta-analysis review, patient reasons for not filling their 
medications were consistently the same.  
In a meta-analysis of 127 articles, Silverman et al. (2011) investigated patient 
reasons for non-adherence to medications used to treat osteoporosis, cardiovascular 
disease, and other chronic disease medications.  They found that suboptimal health 
literacy and lack of patient involvement in his/her treatment decisions by providers were 
reasons patients did not take their medication as prescribed.  Other findings included 
communication barriers about the medications and disbelief by the patients that they 
needed the medication.  Ineffective communication of information about adverse effects 
and too many different physicians caring for multiple patient conditions were also causes 
for non- adherence (Silverman et al., 2011).  Since the prescriptions in this study were 
written largely for bisphosphonates, the findings were generalizable to osteoporosis as 
well as other chronic diseases (Silverman et al., 2011  
 Poor patient health literacy and lack of patient involvement in decisions related to 
treatment were found to be amongst the main contributing factors to PNA in a study by 
Elliott and Marriott (2009).  This study investigated why patients did not initially pick up 
their medications from the pharmacy.  In addition to health literacy problems, older 
people are commonly prescribed complex multi-drug regimens while also experiencing 
declines in cognitive and physical abilities required for medication management.  This 
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could lead to increased risk of medication errors and need for assistance.  This study 
reviewed published instruments designed to assess patients' capacity to self-administer 
medications and to gain useful information.  This information might justify the need for a 
tool to assist the provider in identifying patients who are not picking up or taking their 
medications and intervene through communicating with the patient to prompt them to 
take their medications as prescribed (Elliott & Marriott, 2009).  
 In summary, the patient has a responsibility to make sure he/she has his/her 
questions answered by the provider.  The patient must make sure he/she is 
communicating with the provider and letting the provider know if he/she does not 
understand the instructions given.  The patient’s responsibility is to take a more active 
role and become an active participant in his/her own care.  Patients need to be 
empowered to include themselves in a shared decision-making process. 
Causes of Primary Non-Adherence  
at the Provider level   
 Providers must understand the importance of patient involvement in his/her own 
care.  Patient goals must include the patient—he/she must be included as part of the team 
in a shared decision-making process that will help him/her understand  the importance of  
participating in his/her own care (McCormack & Loewen, 2007).  In a study by 
Giangregorio et al. (2008), patient belief in the perceived importance of the medication 
and the connection to his/her fracture risk was found to be a very important predictor of 
PNA.  One hundred twenty-seven women in their 60s were interviewed about their 
beliefs and the connection between their medication and their own fracture risk reduction.  
The findings showed 82% of the women interviewed had a new prescription for a 
bisphosphonate but no diagnosis of osteoporosis, had no conversation with the provider 
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about the importance of taking the medication, and did not believe there was a link 
between osteoporosis and their own individual fracture risks.  The women in this study 
placed no increased importance on taking prescribed medications for osteoporosis if they 
did not know they had osteoporosis and had no uncomfortable symptoms they wanted to 
treat.  The study concluded that the women did not believe they needed to take 
medication because their doctor did not discuss this problem with them and they had no 
symptoms.  However, when an actual diagnosis of osteoporosis was made in a different 
group of 56 women and compared to those patients without a diagnosis, the patients who 
had an actual diagnosis of osteoporosis believed there was a link between osteoporosis 
and their fracture risk.  Overall, 17% of the women thought their fracture was related to 
osteoporosis.  Less than 50% of the women believed they personally had any risk of a 
fracture (p < 0.001).  This study concluded there is a need for better communication 
between providers and patients and better ways to determine risk of PNA.  If the 
physician does not communicate the importance of the medication or does not note in the 
medical record that this medication is indicated, then the mediation will usually not be 
taken by the patient (Giangregorio et al., 2008). 
 Patient compliance is a key factor to the success of any disease management 
program (Solomon et al., 2003).  It is the provider’s responsibility to make sure patients 
are included as a team member and practice shared decision-making to empower patients 
to feel that their thoughts and feelings are important (McCormack & Loewen, 2007). 
However, compliance and predictions of patient compliance are difficult to measure. 
According to Sale et al. (2011), labelling patients or grouping them into categories such 
as being adherent or non-adherent is not productive because it sets stereotypes and 
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negative messages; the reasons for non-adherence often change with time and are not 
consistent.  Sale et al. (2011) showed that in a university teaching hospital fracture clinic 
program, individuals aged 65 and older who had sustained a fragility fracture within five 
years were at high risk or future fracture; once identified, they were enrolled in the study 
and prescribed a bisphosphonate medication.  More than half of the patients revealed that 
the decision to take their osteoporosis medication was a difficult and usually not a 
permanent one; this substantiated Sale et al.’s findings that a patient’s decision to take a 
bisphosphonate is transient and changes over time.  It is the provider’s responsibility to 
understand this and to maintain consistent interventions designed to enhance 
communication aimed at changing and maintaining patient beliefs and behaviors.  One of 
the reasons cited by half of the patients in the study was patients were unconvinced by 
their health care provider that they needed to take the medication.  Thus, providers need 
to take a more active role in assuring their communications are actually effective; they 
should not just assume without verifying that patients actually understand what is 
communicated or taught to them.  In addition, patients showed concern about side effects 
of the medication.  In the final analysis, many of the patients said their osteoporosis 
medication-taking status might change at a later date and that they are not permanently 
convinced they wanted to take the medication (Sale et al., 2011).  
 Brown and Bussell (2011) found the provider has a responsibility to assure that 
the patient is included as a team member and is allowed to be in the shared decision- 
making process related to their care.  Findings from this study showed that provider level 
related causes of non-adherence including patient-provider communication barriers, lack 
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of knowledge about potential side effects, and lack of health information technology 
systems in place also contributed to PNA (Brown & Bussell, 2011). 
To date, a traditional style of health education has centered on the disease process 
and pathophysiology of disease.  This type of education alone and not in coordination 
with a FLS disease management type program has been shown to be ineffective in 
changing patient behavior such as PNA (Solomon et al., 2003).  Traditionally, the 
physician model focuses on diseases and how they are treated.  Solomon et al. (2014) 
confirmed that if the patient knows more about their disease and is educated with the 
same model of teaching the physician was taught, then the patient will become more 
adherent to prescribed medical treatments.  The education a patient receives must be 
meaningful to the patient; the patient must see the perceived value to him/her before any 
change in health related behavior can occur stemming from provider teachings (Solomon 
et al., 2003).  Solomon and colleagues (2003) explained that although education is 
important and the provider must talk to patients and teach them, without the coordinated 
efforts of a program such as an FLS program and a nurse practitioner (NP) coordinator to 
act as the glue that holds patients and treatments together, education alone will fail to 
impact patient outcomes.  Additionally, Dell (2011) agreed that information technology  
tools and the assistance of an NP-led patient education program without coordinated 
efforts of NP clinic visits will not effectively impact hip fracture reduction (Greene & 
Dell, 2010). 
It is essential that NP coordinators close care gaps if there are to be successful 
results in the effective coordination of meeting care goals (Greene & Dell, 2010; 
Solomon et al., 2003, 2014).  Solomon and colleagues (2003) showed that continued 
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under-treatment of osteoporosis in patients persists; using education techniques alone 
have been completely ineffective.  Despite many attempts to improve patient knowledge 
with patient education classes, the problem remains unchanged.  Patients are motivated 
by different factors; thus, any intervention to improve health literacy must be focused on 
the individual and associated causes (Solomon et al., 2003).  Providers have a 
responsibility to implement techniques that focus on patient needs rather than using care 
delivery that is convenient for the provider.   
The literature clearly showed that the human interaction associated with follow up 
by the NP and phone calls as part of a telephone outreach effort played a key role in 
giving more customized care and enhanced communication as opposed to other studies 
that used only patient questionnaire feedback in which patients claimed they simply 
forgot to pick up their medication.  It is the provider’s responsibility to make sure the 
patient understands the information given during the visit and allows the patient to ask 
questions.  This communication component assists patients in deciding whether or not to 
not take their medications.  In summary, patient reasons for not picking up their 
medications are individualized and transient.  Often, patients who do not pick up their 
mediations did not forget to pick it up but made conscious decisions not to pick up or 
take their prescribed medication.  
In their meta-analysis, Elliott and Marriott (2009) evaluated the development and 
validation of instruments designed to assess patients' capacity to self-administer 
medications.  The authors showed that healthcare providers must persist with 
communicating with patients who have not initiated their bisphosphonate prescription. 
Their meta-analysis indicated that patients might benefit from knowing what to expect 
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from taking the medication and to include benefits and the time it takes to work.  The 
study concluded it is the provider’s responsibility to improve the health literacy of the 
patients as well as maintain their own health literacy. 
 In summary, providers must communicate with the patient the importance of 
taking the medication, what to expect, the benefits of taking it over the long-term, and 
any side effects.  Multiple opportunities are available to use technology to boost patient 
compliance rates and make it easier for patients to become more involved in their own 
care (Elliott & Marriott, 2009).  It is important that the provider include the patient in 
their care and considered the patient as a team member in order to improve patient 
outcomes (Elliott & Mariott, 2009). 
Causes of Primary Non-Adherence  
at the System Level   
 Improvements in health literacy and information technology could contribute to 
better care and a decrease in the incidence of non-adherence (Dell, 2011).  In this case, 
the computer provides information to the NP in real time to assist with tracking patient 
compliance and provides a protocol to be followed for telephone outreach.  The computer 
as part of the system can assist the provider in making a diagnosis of osteoporosis, which 
has been shown to directly improve patient adherence in taking the medication as 
prescribed (Giangrigorio et al., 2008).  Dell (2011) added that the computer can assist in 
this process by providing tools in the form of clinical practice guidelines, risk calculator 
tools, and patient chart information such as diagnostic tests in real time.  These tools 
could assist the NP provider in making the diagnosis and determine whether or not 
treatment is advised.  The computer could enhance better communication by providing 
tools and information that can decrease variation in practice and might add information to 
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dispel myths so a stronger connection can be made between osteoporosis and fracture risk 
by patients (Dell, 2011; Giangregorio et al., 2008). 
 Inclusion of an actual diagnosis on the chart and patient awareness of the 
diagnosis of osteoporosis might improve this association.  The provider could use the 
electronic medical record (EMR) as a useful tool in improving health literacy for other 
healthcare providers as well as patients to reduce the incidence of PNA (Che et al., 2005). 
A clinical practice guideline (CPG) could guide practice and improve communication to 
the patient when it is embedded into the EMR.  Alerts and reminders would tell a 
provider when a patient has not picked up their medication so they can be called and 
communication can be initiated (Cheetham et al., 2013).  The EMR could also be 
programmed with a patient’s past behaviors--the best predictors of future behavior.  The 
computer system is an essential component to the tracking and documenting of patients in 
order to monitor their compliance.   
 Bardwell et al. (2002) examined medication-taking health beliefs in patients and 
analyzed how their beliefs affected their past history of compliance with taking 
prescription medications.  The data were analyzed using a predictive tool comparable to 
one of the functions available as part of the Knowledge Builder Tool (KBT) in order to 
determine if past non-adherent behavior could be used to predict future non-adherent 
behavior.  Results of this study demonstrated it was possible to predict non-adherent 
behavior and predictive models might be helpful tools for providers to use when any new 
prescription is written.  This information could be helpful when revising the program to 
further improve the rate of PNA once current goals are met.  When the problem is 
identified, then the prescriber can adequately intervene with additional communications 
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to help dispel any myths or fears and attempt to change patient beliefs so they can 
understand the importance of taking their medication (Bardwell et al., 2002).  
 Another factor that contributes to PNA at the system level is an inability of 
providers to retrieve patient data and medical chart information so they can provide 
patient care in real time (Dell, 2011; Greene & Dell, 2010; Siris et al., 2006).  As noted in 
the literature, this barrier at the system level might be resolved by the added ability of the 
provider to track whether or not the patient has picked up a prescription medication once 
written.  Lack of electronic prescriptions and an overall lack of communication and 
access to chart information directly affect the PNA rate (Che et al., 2005; Cheetham et 
al., 2013).  Simply put, a treatment cannot work if the patient does not take it and the 
prescriber cannot track it.   
 Lack of integrated systems with pharmacy data and no existing FLS type program 
in place designed to assist the provider minimize PNA have contributed to the ongoing 
problem.  This lack of a coordinated system has made it more difficult for healthcare 
providers to monitor and measure compliance.  Thus, a coordinated system in place 
would assist in lowering the hip fracture rate and improve non adherence through the 
coordinated efforts of a dedicated coordinator (Dell, 2011; Siris et al., 2006, 2012).  Use 
of FLS programs that use a nurse practitioner (NP) coordinator to take responsibility for 
patient care and outcomes and maintain telephone outreach and computer systems are 
helpful in decreasing the hip fracture rate (Cook, 2008; Siris et al., 2006).  Simply put, 
fractures negatively impact patient outcomes due to the lack of proper systems in place 
and lack of medication treatment with a bisphosphonate (Akesson et al., 2013; Dell, 
2011; Dell et al., 2008; Greene & Dell, 2010; Marsh et al., 2011; Siris et al., 2006).  The 
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NP is able to identify, risk stratify, diagnose, treat, and follow up with patients to meet 
program goals.  Bisphosphonate therapy is the best intervention to lower the risk of hip 
fracture and prevent subsequent fractures (Akesson et al., 2013; Dell, 2011; Dell et al., 
2008; Ensrud et al., 1997; Greene & Dell, 2010; Siris et al., 2006). 
 Patient non adherence to medication treatment can have a kind of domino or 
cascade effect--one event affects the other.  If medications are prescribed after a fracture 
occurs and the patient fails to acquire the medication and take it, then he/she does not 
benefit from it and his/her individual fracture risk goes up (Brown & Bussell, 2011; Dell, 
2011; Eisman et al., 2012; Marsh et al., 2011; Silverman & Gold., 2008; Silverman et al., 
2011; Siris et al., 2006).  A coordinated program that considers patient, provider, and 
system factors is necessary to reduce PNA and improve patient outcomes related to 
fractures in patients with osteoporosis.  
 A coordinated program such as the Kaiser Permanente (KP) system could identify 
patients with osteoporosis or who are at risk for hip fracture, systematically intervene, 
and then monitor and follow up with each patient accordingly.  With the system in place, 
the NP could receive a list of patients who have not picked up their bisphosphonate 
prescription from the pharmacy.  The NP in this project would be the key component to 
this coordinated effort.  However, when there is no NP coordinator and no coordinated 
system is in place, the computer alone cannot improve patient outcomes without the 
organized effort of all program components (Solomon et al., 2003).  Without the 
computer system in place, the provider might not be aware the patient is not taking the 
medication and thus not benefitting from the treatment (Brown & Bussell, 2011; 
Cheetham et al., 2013; Marsh et al., 2011; Sale et al., 2011; Silverman & Gold., 2008; 
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Silverman et al., 2011; Siris et al., 2006).  The fracture liaison service (FLS) program and 
theoretical framework would provide the structure and protocols.   
Description of the Knowledge Builder  
Tool and Improvements in Quality 
 
 The days of the paper chart are changing into a new era of the electronic medical 
record (EMR).  The EMR must be designed and organized to facilitate a process that is 
useful and can be used as a tool to close care gaps and to improve patient outcomes while 
maintaining quality at an affordable cost (Dell, 2011).  The KBT takes the data from the 
EMR and converts it into actionable knowledge that can be used by care managers to 
close care gaps.  Data are updated daily and the care manager can receive current 
information about DXA, laboratory results, medication treatments, and demographic 
information.  The KBT updates the current state of the patient’s health condition and then 
populates the information in the form of patient lists, creating a complexly interactive 
disease registry.  The KBT was developed to reduce the barriers associated with 
implementing knowledge into practice with the intention of improving quality care (Dell, 
2011).  The Kaiser Permanente Knowledge Builder Tool (KBT) was developed by the 
internal infrastructure of the Kaiser Permanente Information Technology Department in 
coordination with the Healthy Bones Program; it is being implemented as a component of 
their osteoporosis disease management program to assist the NP care manager in 
managing problems in large populations and closing care gaps such as PNA.  The KBT 
was tested internally by over 50 Kaiser Permanente providers and was shown to be a 
reliable and valid tool (Personal communications, Dr. Dell, physician champion of the 
KPHBP, and Xuan Chen, senior data consultant, on December 12, 2013).  During the 
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year end KPHBP core meeting, the validity of this tool was demonstrated and confirmed 
through an internal validation process (Dell, 2011). 
 The literature provided examples of how the EMR is a useful tool and enhances 
the safety of prescribing and monitoring medication side effects (Cheetham et al., 20l3; 
Halvorson, 2009; Institute of Medicine [IOM], 2006).  It is important to the success of a 
program to incorporate computer technology tools to close care gaps such as PNA.  The 
IOM (2006) publication To Err is Human calls for the use of integrated IT systems to 
reduce the incidence and inefficiencies of the current medical system.  These systems 
could effectively manage chronic health care problems safely and effectively at the level 
of the patient as well as the population.  Halvorson (2009) described the Healthy Bones 
Program (HBP) as an ideal example of how a chronic disease management program 
should work.  The HBP has made great contributions to healthcare delivery through early 
identification of problems.  This program helps overcome barriers to meeting quality 
improvement goals.  It is an example of a coordinated system that uses IT and NP care 
coordination to reduce hip fractures.  The HBP uses the EMR and tools such as the KBT 
to provide the means through which adherence of patients with chronic health issues such 
as osteoporosis can be monitored, managed, and tracked (Dell, 2011; Halvorson, 2009).  
These systems facilitate management of side effects, improve safety and efficiency of 
practice, and close care gaps.  The KBT was developed internally as a part of the EMR 
that is used to collect data and provide NPs with specific patient lists to address persisting 
care gaps--in this case, PNA (Dell, 2011; Halvorson, 2009). 
 Katzen and colleagues (2011) also supported the future development and use of 
the EMR and tools that could store and use clinical and administrative data.  With an 
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EMR, the data are typically stored in a central warehouse and can be accessed directly 
and in real time (Katzen et al, 2011).  Clinical decision support tools found in EMRs 
aimed at improving compliance have made great contributions to the improvement of 
primary non-adherence to medication (Kastner & Straus, 2009).  Clinical decision 
support tools such as the KBT within an FLS program could be used to close care gaps 
and use the evidence to directly translate knowledge into practice.  This practice 
translation is evidenced by improvement in patient outcomes.   
 Kastner and Straus (2009) advocated clinical decision support and the application 
of knowledge into practice by using a decision support tool and a knowledge to 
application model of care to transform information to knowledge to practice.  In Crossing 
the Quality Chasm: A New Health System for the 21st Century, the Institute of Medicine 
(IOM; 2010) described PNA as an example of a care gap.  The IOM discussed the benefit 
of using knowledge to close care gaps.   
Limitations of the Literature 
 Over the past decade, much energy has been focused on FLS program model 
development as a cost-effective team approach to reduce fracture risk through 
coordinated program efforts.  The American Society of Bone and Mineral Research 
(ASBMR), National Osteoporosis Foundation (NOF), International Osteoporosis 
Foundation (IOF), and others have recommended the implementation of coordinated FLS 
type programs to prevent fracture and lower the hip fracture rate (Eisman et al., 2012; 
Marsh et al., 2011).  To date, a paucity of research is available related to addressing the 
PNA problem (Eisman et al., 2012).  Eisman et al. (2012) reported on recommendations 
made by the ASBMR Task Force for the implementation of an FLS type service geared 
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toward early identification and initiation of a bisphosphonate and the monitoring of 
patients on medication treatment to lower the incidence of preventable fracture (Dell, 
2011; Eisman et al., 2012; Marsh et al., 2011).  
 Although researchers gave recommendations for fracture prevention based on 
current available knowledge and from their own work and programs, hip fracture remains 
an ongoing problem.  The ASBMR Task Force synthesized the literature and published a 
position paper providing recommendations that have been described in this paper 
designed to improve care delivered from the systems level (Eiseman et al., 2012).  The 
literature verified that not initiating treatment post fracture would result in a poor 
outcome (Eisman et al., 2012; Marsh et al., 2011).  The FLS model of care focuses on 
early identification and treatment initiation post fracture.  In a prospective observational 
study, Kates and colleagues (2012) examined 562 hip fracture patients and found that 
32% of patients with hip fracture who were not treated with a bisphosphonate were 
readmitted to the hospital within the first year.  Subsequently, Kates and colleague also 
showed that the initiation of a fracture management program, including early initiation 
and monitoring of treatment post fracture, reduced readmission rates due to re-fracture to 
10.3%.  Thus, a coordinated program that used a coordinator and a coordinated IT system 
could reduce the rate of re-fracture by preventing fracture.  Kates and colleagues 
attributed their success in improving patient outcomes to early treatment initiation with a 
bisphosphonate and patient monitoring of the treatment.  However, no studies identified 
how to overcome barriers such as PNA. 
 In 2003, Boockvar et al. found similar results in an observational study in which 
they confirmed that patients who were not adequately treated post fracture were often re-
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hospitalized and had bad outcomes.  Both Boockvar et al. (2003) and Kates et al. (2012) 
found success in implementing similar FLS techniques of early treatment initiation and 
monitoring of treatment adherence compared to those organizations without a program in 
place.  Information technology makes it possible to monitor large and growing 
populations of patients that cannot be done by hand in a paper-based system; thus, a 
computer is a necessary component (Che et al., 2005; Cheetham et al., 2013; Dell, 2011).  
Use of an FLS coordinator-based program has been shown to have some of the solutions 
but there are limitations.  One of the limitations is FLS programs have not been able to 
connect all of the necessary components to close all care gaps such as PNA.  It is 
important that solutions be found to this problem and those solutions must be translated 
into practice. 
 Primary non-adherence (PNA) has been discussed as being caused by failures at 
the patient, provider, or system levels.  Literature supported programs that incorporate the 
FLS model of care, telephonic outreach, EMR, and integrated pharmacy systems as 
necessary components of a successful disease management program.  To date, attempts 
have been made but no one has been able to integrate all needed components (Kastner & 
Straus, 2012).  
 In spite of studies (Gadkari & McHorney, 2010; Giangregorio et al., 2008; 
Greenwald & Farnham, 2000; McHorney & Spain, 2011; Sale et al., 2011) on primary 
non-adherence to bisphosphonate medications, major inconsistencies in evidence and 
definitions regarding compliance have made it difficult to compare them.  Additionally, 
lack of consistency in study results and lack of systematic reviews have further 
compounded addressing the issue of PNA.  Commonly, studies use small population 
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sizes, making generalizability difficult.  After an extensive literature search, it was found 
that for such an important issue, very limited information was available on PNA in 
general.  Methodological limitations included use of self-report questionnaires in some 
studies compared to predictive models that used past behavior data to predict future 
behavior.  Many of the studies identified problems but did not give solutions.  Reynolds 
et al. (2013) identified the problem of a 29.5% PNA rate in the program they studied but 
offered no solutions of how to improve on it.  Given this limitation, it is important for 
studies to focus on solutions and make recommendations for possible future studies. 
 The literature consistently showed that patient education techniques alone do not 
work and have failed miserably in affecting outcomes (Eisman et al., 2012; Solomon et 
al., 2003).  The only benefit seen was patients learned that osteoporosis is a serious health 
condition and it might have serious health consequences, but it did not improve patients’ 
ability to connect osteoporosis and hip fracture reduction to their medical treatments 
(Solomon et al., 2003).  Additionally, Cook et al. (2007) found that patients’ reasons for 
not picking up medication usually had a psychological aspect such as fear of side effects 
and needing to overcome denial of having a chronic condition, feeling the medication 
was not important, that they did not need the medication, and that they did not want to 
spend the money on it because they believed a good diet was sufficient to prevent 
osteoporosis.  Many patients, even after extensive medication education, still did not 
adhere to taking it and stated that although they understood osteoporosis is a serious 
condition, they did not make the connection between osteoporosis and the fracture and 
how the medication would prevent fracture.  The main limitation of the literature was the 
studies did not give solutions to how the problem of PNA could be resolved.  Although 
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informational, the articles especially did not provide recommendations that could be 
translatable into practice. 
 Another study (Siris et al., 2006) confirmed that when patients do not have 
symptoms, they do not feel motivated enough by education about the disease to take a 
medication.  Since osteoporosis does not have a symptom until the fracture event, 
patients do not always understand the importance of taking their medication.  The 
literature had direct application to this capstone project because patients who are screened 
for osteoporosis might not understand the importance of taking their bisphosphonate 
medication because they do not have symptoms until the fracture event and sometimes 
after the fracture has occurred.  Although health education is an important topic, it should 
be left to health educators.  Teaching classes is not the best time spent by the NP health 
provider when patient identification, risk stratification, treatment, and follow up have 
been shown to be more effective.  Bisphosphonate treatment is the most effective way to 
reduce a person’s risk for fracture.  However, if they do not take the medication, they do 
not get the benefit of fracture risk reduction. 
Summary 
 Primary non-adherence (PNA) has been discussed as being caused by failures at 
the patient, provider, or system levels.  Literature supported programs that incorporated 
the FLS model of care, telephonic outreach, EMR, and integrated pharmacy systems as 
necessary components of a successful disease management program.  To date, attempts 
have been made but no one has been able to integrate all needed components (Kastner & 
Straus, 2012).  
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 The literature has shown that patients with a first time prescription for a 
bisphosphonate were not all picking up their medications.  This problem has sparked an 
interest to develop a system and protocol that could be applied to improve PNA.  
Evidence-based guidelines are ineffective unless they are implemented and the evidence 
must be translatable into practice.  The implementation of an osteoporosis disease 
management program, especially if an electronic health record is used, is an effective tool 
in lowering the hip fracture rate.  Through the use of clinical practice guidelines and 
guidance practice of the staff trained with TBP, acceptance and implementation of such 
systems would facilitate changing current provider behaviors.  The literature did not 
clarify all factors concerning the reasons for PNA.  There is still much confusion and no 
standardization of terms and definitions, which makes describing the problems and 
solutions difficult to compare between studies.  This capstone project implemented a 
protocol for which outcomes were measured to determine its effectiveness in addressing 
the problem of medication adherence in patients with osteoporosis.  Once standardization 
is established, other researchers can build upon it instead of recreating and applying new 
terms to what has already been established. 








 CHAPTER II  
 
 




 Primary non-adherence (PNA) to bisphosphonate medication is a growing 
problem that needs to be addressed by an osteoporosis/fracture prevention/disease 
management program.  Hip fracture reduction goals can best be achieved by having all 
the care gaps easily identified with the help of information technology tools.  These tools 
incorporate all the clinical practice guidelines of the organization’s osteoporosis/fracture 
prevention program and automate the steps to identify all patients who have a care gap 
related medication non-adherence.  Not taking a prescribed bisphosphonate increases the 
risk to the patient for future fractures.  By developing a procedure reflecting the most 
recent research evidence, the Doctor of Nursing Practice (DNP) student wrote a protocol 
for telephone outreach in collaboration with organization leaders to improve the 
incidence of primary non-adherence to a bisphosphonate. 
Objectives of the Study 
 Two objectives were identified in this study.  The first was to develop and 
implement a protocol to target patients diagnosed with or at risk for osteoporosis and hip 
fracture who had not picked up their bisphosphonate medication from the pharmacy 
within 60 days.  The second objective was to decrease the current rate of PNA by 20% 
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from its identified rate of 29.5% in order to be clinically significant during the study 
period, which spanned four months.  
Study Design 
 This prospective observational study was designed to determine the effect of 
using an information technology tool at the facility to systematically identify all patients 
at potential risk of becoming non-adherent to their anti-osteoporotic medications over a 
period of 60 days.  The data collection lasted approximately two months (n = 216); the 
study followed each patient for 60 days or until he/she picked up the medication.  The 
care manager at the medical facility was a nurse practitioner (NP) and was part of the 
program.  She provided the patient care and coordination.  This study used the Reynolds 
et al. (2013) article as a benchmark in setting a goal of using approximately 216 patients 
in an attempt to lower the rate by at least 20%. 
 The program uses a systems-based approach to disease management to monitor 
and change a course of action.  Applying the theory of planned behavior (TPB) to guide 
patients’ decisions to develop an intention to pick up and then take their medication, the 
nurse practitioner (NP) used a telephone outreach protocol to enhance communication, 
build rapport, and assist patients in getting the information necessary to resolve issues 
leading to non-adherence.  Adoption of this method allowed for improvements in 
efficiency and effectiveness and maximized the time to accomplish it as expediently as 
possible.  This method enables researchers to apply the same protocol to each patient 
equally and minimize disparity (Navarro, Greene, Burchette, Funahashi, & Dell, 2011).  
The NP used the protocol to guide the practice in the right direction.  Productivity was 
monitored and measured to maintain a course of action and adopt the new protocol.  
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Setting and Study Population 
 The study included all patients aged 55 and older who had a new prescription for 
a bisphosphonate medication and no history of ever having a bisphosphonate prescribed 
to them.  The patients were entered into the disease management registry and had a dual 
energy X-ray absorptiometry (DXA) scan or a diagnosis of osteoporosis that was not 
exclusionary.    
 Patients were excluded for the following reasons: 
1. Patients who were not Health Maintenance Organization (HMO) members 
or who had died or been terminated from their insurance.  
2. Those patients who had a history of taking a prescription or had taken a 
bisphosphonate in the past. 
3. Patients with chronic kidney disease (CKD) 4 or 5 or if they were on 
dialysis.  
4. Patients with diagnosed hypocalcemia.  
5. Patients with allergies or other contraindications to taking a bisphosphonate.   
 Patients who were excluded at any time were not carried through in the data base 
tool population for the purposes of this study only. 
 The study setting was an NP-led disease management program.  The following 
patient demographics were currently in the system and were extracted from the 
department for use by the program: (a) age, (b) race/ethnicity, (c) gender, (d) diagnosis of 
osteoporosis (if there was one), (e) score from DXA scan, and (f) diagnosis of a fragility 
fracture (hip, distal radius/ulna, spine, humerus, pelvis, and other femur).  All were 
confirmed to have a prescription for a bisphosphonate.  
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Background of the Fracture Liaison  
Service 
 
 The program began in 1998.  It has a 16 year history of using teams and 
technology in reducing fracture rates and saving money.  This study’s focus was the role 
information technology tools played in translating evidence into practice in order to 
improve patient outcomes.  Current practice protocols reside in the osteoporosis/fracture 
prevention clinical practice guideline (CPG).  The organization’s 3.7 million members’ 
records are automatically updated every day with the use of the Knowledge Builder Tool 
(KBT).  The KBT automates the steps in patient enrollment, applies the rules of the CPG 
protocol, and determines actions needed.  Patient data are displayed as well as actions 
needed in a secure, password protected, and user-friendly interface.  The system receives 
feedback from the program nurse practitioner (NP) care managers when they work within 
guidelines developed to close care gaps. 
 The average care manager spends several hours a day searching for patient data or 
screening patients to determine each patient’s appropriateness for the program (Dell, 
2011).  It is very time consuming for the NP to search data in order to generate 
appointments for patient encounters or to conduct program outreach operations.  The 
KBT cuts down tremendously the amount of time it takes for someone to manually search 
for information.  Thousands of records can be sifted by the computer and an updated list 
can be generated on a daily basis, thus allowing the NP to work the list, organize time, 
and set priorities more efficiently.  The time it takes for the KBT to run a report on 3.7 
million records is the approximate time it takes for a NP care manager to review one 
complete patient chart.  The power and speed of this tool is unmatched by anything that 
can be done manually (Dell, 2011). 
52 
 
 This medical center has run previous pilot projects and was the first site to roll out 
implementations to address care gaps in osteoporosis and fracture prevention.  This site 
volunteered to be the beta testing site of the new tool to address PNA and was the site to 
implement this study.  The patient intervention group had data collected on 
bisphosphonate prescriptions and tracking of dispensed bisphosphonate medications.  
There was no control group.  The number of days from the time the medication was 
prescribed to the day of pickup was tracked and measured within a 60 day period using 
percentages and a questionnaire.  A Likert scale for the interview questionnaire measured 
NP beliefs before and after the intervention and patient beliefs were measured by a yes/no 
questionnaire in the form of a telephone outreach tool. 
Description of the Knowledge Builder Tool 
 
 The Knowledge Builder Tool uses an SAS-based 9.2 program with Enterprise 4.3.  
There are many advantages of using the SAS version of the Knowledge Builder Tool.  It 
is a far superior development platform for disease management registries used by all the 
health plan organization’s sites.  The KBT is built from a toolkit of over 1,000 modules 
and is able to capture data from laboratory results, diagnostic tests, clinic visit notes, 
hospitalizations, surgical history, and other data housed in the clarity data warehouse 
(CDW).  Data are updated on a daily basis.  The chosen data components are downloaded 
daily into the disease management program and patients are placed onto a list worked by 
the NP care manager.  The various parts of the registries can be used by NP care 
managers to manage a patient’s care gaps (Dell, Loo, & Loomis, 2012).  For example, the 
FLS team recently started implementing the new osteoporosis/fracture prevention clinical 
practice guideline (CPG) as well as several new guidelines addressing such things as drug 
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holidays for bisphosphonates and re-DXA schedules based on the last DXA result.  New 
recommendations to address primary medication non-adherence are currently being 
updated and added (Kanter, Lindsay, Bellows, & Chase, 2013).   
 The KBT began as a disease management registry in 2011 and since has expanded 
to incorporate clinical practice guidelines in an interactive and dynamic data registry tool 
that can address all care gaps and patient needs programmed into it (Dell et al., 2012).  
The registry is updated on a daily basis from the CDW described earlier.  For example, a 
patient with a need for screening will be targeted as “needs DXA” so the NP will receive 
a list with all needed information so this care cap can be addressed.  For the PNA tool, 
the same thing applies.  All care gaps are decided upon by the program and become 
strategic goals.  On a yearly basis, the data are matched with existing guidelines to ensure 
the guidelines are being followed. 
 By using the KBT, it is possible to convert the rules inherent in the new 
osteoporosis/fracture prevention and CPG into modules that capture certain rules and 
apply them.  The FLS nurse practitioner care manager is able to see the daily updated list 
of patients who have one or more of the care gaps and address each.  For the purpose of 
this project, they addressed the care gap of primary non-adherence (PNA).   
 The KBT is built with knowledge builder modules that have global variables to 
allow SAS developers to very quickly change the variables to see the medications and 
monitor them, as in the case of bisphosphonates.  This program tracks all patients with a 
certain diagnosis, such as osteoporosis, or a prescription for a certain drug; it searches the 
CDW to find which patients are prescribed this medication or have this diagnosis and 
then downloads the information to the NP care manager.  According to Che et al. (2005), 
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closing care gaps and using measures, such as healthcare effectiveness data and 
information sets (HEDIS) to determine how to stay compliant with meeting quality 
measures, are important components in identifying and closing care gaps, especially in 
the prevention of fragility fractures such as hip fractures--one of the most debilitating of 
all fractures.  The tool was originally developed as a part of the organization’s safety net 
project where it was extensively tested and validated.  The KBT program applied lessons 
learned from previous studies and developed useful guidelines, such as osteoporosis with 
this intervention study.  
 The Complete Care program, also sometimes referred to as Safety Net Project, 
provided a care framework that changed systems within the organization in many ways 
across multiple levels and provided an avenue for validating the KBT.  An article by 
Kanter et al. (2013) showed examples of the care teams who used clinical decision 
support of the KBT and how it was integrated across different sites.  This article 
described how the tool was accepted and validated.  Work on this project was undertaken 
to break down care silos and act as a way to provide aggressive outreach/care 
management services for individual patients as needed to achieve care goals and close 
care gaps (Kanter et al, 2013).  The KBT was validated through many studies.   
The KBT was developed so it could be interfaced with the electronic medical 
record (EMR) to target and close specific care gaps in various disease management 
programs within the system.  An information technology tool based on Drools Guvnor 
(Dell et al., 2012.) software was selected to be the foundation and the principle rule upon 
which the Knowledge Builder Tool (KBT) was built and validated.  The KBT is basically 
a relational database management system that can be transformed into a database system 
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according to an individual user’s needs.  Access to the KBT is controlled and password 
protected; it is possible to lock down and restrict access so only approved individuals can 
view and make edits.  The tool is automated and includes internal components of decision 
making.  This enables providers to focus on treatment and follow-up by having 
information readily available  
Ethical Considerations 
Institutional Review Board 
 Since this was not an experimental study, exempt review was sought and obtained 
from the Institutional Review Board (see Appendix A).  Each participant signed a consent 
form agreeing to participate in this research study (see Appendix B).  There was no 
experimental or control group.  The DNP student researcher did not have any direct 
contact nor made telephone calls to patients.  This was the responsibility of the 
organization’s nurse practitioner care manager.  The NP coordinated all care related to 
the management of the patients.  The student researcher directly communicated with the 
care management team and staff members for the duration of the study.  All ethical and 
legal considerations were observed with respect to privacy of patient electronic medical 
records.  The DNP student researcher obtained Institutional Review Board (IRB) 
approval from the HMO where the study was conducted (see Appendix C).  The DNP 
student reviewed chart records to gain information and track patient performance.  
Patients were given anonymity through the use of a unique identifying number and to 
prevent duplication.  All patient information was encrypted and password protected and 
all information in the records was protected to the highest level of security as possible. 
56 
 
 All patients were notified that they were being enrolled in the FLS program--a 
regular component and service provided by their health plan.  They were not coerced or 
forced to participate in any way.  All patients were given an opportunity to refuse to 
participate.  Patients who chose not to participate were marked as PNA and removed 
from the study.  If at any time the patient had a change of interest, he/she was easily 
added to receive the full services the FLS program had to offer them.  Patients who 
dropped out of the program were encouraged to follow up with their primary care 
provider (PCP) in order to have access to an ongoing continuity of care.  All patient 
privacy was upheld by the laws of the organization and all state and federal laws such as 
Health Information Privacy and Accountability Act (HIPAA) were observed.  Patient 
information was not shared outside of the study’s environment.  
Memorandum of Understanding 
 The Memorandum of Understanding (MOU; see Appendix D) was an agreement 
between the DNP student researcher and the organization.  The role of the DNP student 
and involvement with the study were outlined as follows: 
1. The DNP student would actively work with staff members in the FLS 
program, the physician champion, the information technology department, 
and leaders and front line care managers from the Osteoporosis/Fracture 
Prevention Disease Management Program.  
2. The new protocol as written provided a framework for NP practice.  The 
DNP student trained the NP regarding the protocol steps and the theory 
behind it.  Training was for the purpose of increasing the NP's knowledge 
base and improving her ability to integrate and disseminate the new protocol 
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successfully.  This was done during a face to face meeting with senior 
leadership in December of 2013. 
3. The DNP student would work with the existing staff of the program.  There 
was no direct patient contact by the student. 
4. The organization would like to be referred to as a large HMO in Southern 
California. 
5. The DNP student researcher would interface with staff members and 
physician champion and have access to patient records only.  There was no 
direct contact of the student researcher with patients.  The student attended 
meetings by phone and face-to-face and was onsite for specific meetings.  
Most interaction was by telephone or email.  All patient information was 
kept confidential and this study had already received organization approval 
(see Appendix C). 
Goal of the Study 
 The study goal was to align and advance current nursing practice with the best 
available evidence and current clinical guidelines for osteoporosis chronic disease 
management and fracture prevention with the goal of improving the existing PNA rate by 
20%.  This study measured changes in PNA rate through the implementation of a 
telephone outreach protocol.  Other healthcare delivery systems might see the benefit in 
implementing an FLS program and use similar systems to meet various goals and close 
all existing care gaps.  Additionally, the basic design of this tool was compatible with the 




Desired Outcomes of the Study 
Attitudes and Behavior 
 
 The theory of planned behavior (TPB) specifies the nature of relationships 
between beliefs and attitudes.  A person’s evaluations of or attitudes toward behavior are 
determined by their actions and behavior.  A belief is defined as the subjective 
probability that the behavior will produce a certain outcome.  The theory of planned 
behavior's positive evaluation of self-performance of the particular behavior is similar to 
the concept to perceived benefits, which refers to beliefs regarding the effectiveness of 
the proposed preventive behavior in reducing the vulnerability to the negative outcomes, 
whereas their negative evaluation of self-performance is similar to perceived barriers. 
 In this study, the NP acted as the change agent--the entity who causes the change 
to occur (Rogers, 2003).  By implementing the protocol, the NP began an action that was 
predicted to bring about positive change in the patient’s behavior.  The goal was to get 
patients who had not picked up their medication after 14 days to change their intention, 
then change their behavior, and pick up the medication.  It was believed the telephone 
call would be instrumental in changing the patient’s behavior.  Patients were asked 
questions during the call, which in turn measured their responses and beliefs.  The NP 
was a critical component in the process of changing the patient’s behavior from not 
picking up the medication to picking up the medication from the pharmacy.  It was 
important for the NP to have positive feelings, attitudes, and beliefs about her individual 
influence and control to effect change in each individual patient she encountered.  
Behavior and behavioral intention are defined as follows: 
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 Behavior.  An individual's observable response in a given situation with respect 
to a given target.  Ajzen (1991) said a behavior is a function of compatible intentions and 
perceptions of behavioral control; perceived behavioral control is expected to moderate 
the effect of intention on behavior, such that a favorable intention produces the behavior 
only when the perceived behavioral control is strong.  
 Behavioral intention.  An indication of an individual's readiness to perform a 
given behavior.  It is assumed to be an immediate antecedent of behavior (Ajzen, 1991).  
It is based on attitude toward the behavior, subjective norm, and perceived behavioral 
control with each predictor weighted for its importance in relation to the behavior and 
population of interest. 
Self-Evaluation Questionnaire of the  
Nurse Practitioner 
 Below is an example of the way NP beliefs data were collected to determine her 
state of beliefs and attitudes before and after the staff education regarding the theory of 
planned behavior (TPB) and its application to the study (see Figure 2).  The telephone 
outreach tool was presented to the NP and her opinions and beliefs were measured.  The 
NP was asked to rank the responses of her beliefs before and after the study (see 


























































Figure 2.  Flow diagram of how the theory of planned behavior effects change in  
attitudes and behavior of patient and nurse practitioner. 
NP has an attitude existing about risk verses benefit 
And an attitude about preferences/biases related to this topic 
The NP has had some success with change in the past 
Normative/Subjective Beliefs 
The NP realizes that participating in this it is expected by work 
colleagues and it is the right thing to do peers 
The NP receives training and gains more information about the 
needed change and the protocol itself. Evidence is presented to NP. 
 
 
The NP is presented with the information about 
the problem of PNA in her patient population and 
is told that a change is coming 
Behavioral intention is developed by the NP. The NP then acts as  
Change agent and gets the patient to develop intention and then 
change behavior. 
Perceived Behavior Control 
Result is that the desired change in behavior or belief 
occurs in the NP first and then the patient.  The 
patient then acts and picks up the medication 





 Both patient and NP responses were yes/no on the tool and then further broken 
down on Likert scales to show specific effect and strength on behavior change.  The 
evidence being collected for this project was the patient and NP beliefs before and after 
the intervention.  This was analyzed and based on TPB principles.  The principles of TPB 
that influence intention development and behavior change were normative, subjective, 
and perceived control and are described as follows: 
1. Subjective norm: The belief that the person is doing the right thing. 
2. Social norm: The belief that the behavior is what is expected of them to do 
by others such as peers or superiors. 
3. Perceived behavior control: The belief that the person has control over the 
ability to make the change happen. 
The patient evidence was collected from the feedback from the telephone calls, patient 
responses, and the outcome showing the patient picked up their medication or not.  The 
NP behavior was important but only as it facilitated patient behavior change.   
Evidence-Based Study Intervention 
 
 This study used a theory-based protocol developed by the DNP student and given 
to the staff of FLS program, specifically the NP.  This protocol was intended to improve 
the staff’s knowledge, self-efficacy, and skills concerning PNA.  Using the protocol, the 
NP acted in the role of change agent.  This action of calling the patients would effect 
change in patient behavior and as a result, a change in intention and behavior would 
occur, thus improving outcomes in PNA.  The study plan was to investigate the impact of 
implementing an FLS program telephone outreach protocol on the rate of PNA.  The goal 
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ws to lower the rate of primary non-adherence by 20% within a two month period.  
Studies have shown this to be a feasible and cost effective goal (Che et al., 2005; Dell & 
Greene, 2010; Eisman et al., 2012; Kates et al., 2010; Reynolds et al., 2013; Solomon et 
al., 2014).  The theory of planned behavior was used as a theoretical framework to guide 
practice and the beliefs of the providers and the patients.  
 Information technology and NP care managers systematically identify and target 
patients who are at risk for PNA.  The outcome would be to prevent them from 
progressing to PNA.  This plan began from a need for an intervention to assist patients to 
pick up their bisphosphonate medication.  Previously, no action or intervention has 
worked with patients who did not pick up or take their bisphosphonate medication.  A 
protocol was developed and tested that identified patients who had not picked up their 
medication within 14 and 60 days.  The nurse practitioner (NP) received a list of patients 
from the computer and then worked the list by calling each patient on the list at different 
increments of time such as at 14, 30, and 45 days.  During each telephone outreach call, 
the NP used a protocol that consisted of a series of questions to identify why the patient 
did not pick up the medication.  The NP used an evidence-based solution to change the 
patients’ intentions to get them to pick up and take the medication, which they would not 
have previously done without the intervention.  The protocol demonstrated how the 
theory of planned behavior (TPB) concepts was used as a basis for change in patients’ 
behavior related to primary non-adherence (PNA).  The effects of the protocol, developed 
using evidence-based guidelines and TPB on the patient’s intention and behavior change 
to pick up and take their medication, were measured.  The NP applied concepts of TPB to 
address patient beliefs and guide behaviors regarding taking their medications.  The NP 
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addressed each factor and evaluated what could be done to get the patient to pick up the 
medication.  For patients in the study, the reasons why they did not pick up the 
medication and action by the NP were noted. 
 The following NP actions were taken during the implementation of the protocol 
and evidence was collected during the telephone outreach protocol (see Appendix F): 
1. The NP answered patient questions and engaged in education as needed. 
Effective communication was evidenced by patient answering a 
questionnaire during the call. 
2. The NP made an appointment for patient to come for a face-to-face care 
management visit. 
3. The NP changed the medication if the patient did not want this one.  For 
example, the patient might need to have the medication changed from a 
weekly to a monthly dosage. 
4. The NP removed patient from the list if patient refused to take the 
medication or just did not want to be called.  Patient was referred back to 
PCP.  If the time went past 60 days and patient did not pick up the 
medication, then he/she was PNA. 
5. If patient concern warranted a switch of medication because of a medical 
contraindication, medication was stopped until specialty approval was 
given. 
6. The NP referred the patient back to the PCP or specialist for any concern or 
any reasons deemed necessary by NP. 
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The plan for educating the staff was described including content, strategies for delivery, 
and using TPB as rationale for specific strategies to change staff behavior.   
 A face-to-face meeting was held in December 2013 for the purpose of staff 
education and orientation.  At the meeting, the Reynolds et al. (2013) study and its results 
were discussed in detail.  The staff understood that this study was being used as a base of 
comparison or benchmark.  At this meeting, goals for PNA were set at a reduction of 
20%.  It was decided that a pilot site would begin developing a protocol.  A second 
meeting was held on May 20, 2014 where the staff was given information about the 
protocol questions, more on the TPB and self-efficacy, and the importance these theories 
would have to the study.  This site volunteered to be the pilot and testing site.  However, 
although all staff received information about the study, only one NP implemented the 
protocol.  The student researcher developed the protocol along with the NP and the 
physician advisor.  Prior to this, no protocol was in place.  The telephone outreach 
protocol was discussed completely at this meeting.  The study design was discussed and 
the NP agreed to do this. 
Plan for Staff Education and Training 
 
 The plan for educating the staff included content and strategies for delivery that 
used TPB as a rationale for specific interventions, which led to a change in staff beliefs 
and behavior.  The staff consisted of one nurse practitioner from this site.  Other staff 
members working with the FLS program at other locations had access to the information 
and training but did not participate in the actual study.  All FLS program staff were 
educated to the changes and implementation of the PNA study.  This training was only in 
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anticipation of expanding this program to other health organization sites.  Staff were 
given a copy of the protocol and information related to TPB.   
 The development of translatable knowledge involved steps that first identified 
patients with a care gap related to not picking up a new prescription medication from the 
pharmacy.  It was important to risk stratify this population into groups that need specific 
care gaps, in this case--primary non adherence (PNA) to prevent a bad outcome.  This 
systematic approach was the best way to manage the care gap of PNA as well as track 
patients over time.  The NP care coordinator took responsibility to take appropriate action 
to get patients to change their behavior through a coordinated program that would result 
in better adherence to treatment recommendations.  The protocol and care plan included 
information technology tools that would help in the care being delivered.  The care team 
needed to be all on the same page including the patient who must be considered as a 
member of the team.   
Budget and Financial Disclosures 
 The resources used were the existing staff of the FLS program.  The existing staff 
implemented a telephone outreach protocol to call patients who had not picked up their 
prescription medications at different incremental time periods.  The staff used existing 
departmental space and computer equipment they used every day in their regular job 
function.  No new budget was created.  As appropriate to the individual study and 
determined by the advisor and mentor, the DNP student included a market analysis, 
strategic analysis, product/services, or financial plan that justified the need, feasibility, 
and sustainability of the study (see the financial impact section in Chapter I). 
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 There was no set budget for this research study.  The DNP student researcher was 
a non-paid volunteer and not an employee of the organization.  This was not a grant 
funded project.  There was nothing financial to disclose and there was no conflict of 
interest.  This program was designed to be self-sustainable.  The whole disease 
management team was involved in the education and planning of this project including 
all managers, physician champions, and NPs at all other organization sites.  These staff 
members were educated to the PNA protocol because it was planned to be expanded to 
their sites after it was first implemented at the facility.  Other staff members were aware 
and updated but were not involved.  It was predicted that the final results of this project 
would prove to be a cost savings to the organization.  Studies have shown that non-
adherence to mediations is costly to the organization and to the healthcare system in 
general.  Patients do not benefit from medications not taken.  This problem could result in 
serious consequences and bad patient outcomes.   
Primary Non-Adherence Workflow Process  
for Telephone Outreach 
 The process of using the information technology tool to identify patients who had 
not picked up their medications within 60 days involved the NP receiving a list of 
patients each week who had a prescription and had not picked up their medications.  The 
NP called the patients at 14 days.  After 14 days, the NP documented whether or not she 
had been able to reach the patient and the response.  At 30 days, the patient was called 
again and an internal message sent to the primary care physician (PCP) that the patient 
had not picked up the bisphosphonate prescription from the pharmacy.  Then after 45 
days, the patient was called again and a letter sent to the patient encouraging them to 
make an appointment to follow up with their PCP.  For the purpose of the FLS program, 
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the patient stayed on the list until the NP took them off and they remained on the list for 
further follow up.  However, for the purpose of this study, the patient was no longer 
followed after 60 days and was considered PNA (see Figure 3 for diagram and letter sent 
to patient and provider in Appendix G). 
 
 
Figure 3.  Timeline for protocol. 
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The Study and Agency Strategic Plan 
 
 The organization desired to have a strategic plan in place to lower patients’ risk of 
hip fracture through early identification, risk stratification, treatment initiation, 
intervention, and follow up of patients.  Many of the patients (29.5%) targeted with a 
bisphosphonate treatment were not picking up their medication from the pharmacy.  This 
identification sparked an interest in developing a protocol to improve the rate of primary 
non-adherence (PNA) to a new prescription for a bisphosphonate with the overall goal 
being improved patient outcomes through less hip fractures.   
 The plan in this study reflected how the concepts in TPB were used as a basis for 
strategies in the protocol that was developed.  This included an example of the strategies 
that impacted patient beliefs regarding taking their medications.  This was evaluated by a 
Likert scale developed by Morisky, Ang, Krousel-Wood, and Ward (2009) who were 
able to show that adherence to medications could be evaluated through six domain topics: 
(a) knowledge, (b) attitude, (c) , (d) social support, (e) stress, (e) coping, and (f) 
medication complexity.  The new protocol fit within the existing framework of the 
organization’s policies for the FLS program.  Primary non-adherence was considered a 
new care gap that must be closed.  The Knowledge Builder Tool (KBT) is a computer 
system that has each care gap listed inside.  The NP clicked on the list of patients who 
needed an intervention and then proceeded to work the list according to the clinical 
practice guideline embedded under each specific topic.  In this case, it was the 




 The telephone outreach tool questionnaire has been piloted.  Nor has this specific 
situation ever been studied.  However, the questions were developed from a validated 
tool to measure medication adherence in an outpatient setting (Morisky et al., 2008).  The 
outreach tool was based on the domains derived from the Morisky tool.  Each question 
was developed to relate to one of the following domains: 
1. Knowledge 
2. Attitude 
3. Social support 
4. Medication complexity 
5. Stress 
6. Coping.  
Timeline of Study Phases 
 The timeline was four to five months in duration--two months consisting of 
patient enrollment, approximately two additional months to conduct the study, and one 
additional month to analyze and prepare the results.  Each patient in the study was 
followed for 60 days or until he/she picked up the prescription from the pharmacy.  The 
study began when the initial proposal was accepted by the researcher’s doctoral 
committee and the proposal was been approved by the University of Northern Colorado’s 
Institutional Review Board (see Appendix A).  Then the following phases were 
implemented: (a) recruitment phase was two months, (b) protocol implementation phase 
was 60 days for each patient enrolled in the study, (c) data collection phase lasted 60 days 
for each patient recruited, (d) data analysis began two weeks after the data were all 
collected, and (e) evaluation phase was congruent with the two weeks of the data 
70 
 
analysis.  Evaluations were ongoing during the study while NP evaluation data collection 





Timeline of Phase Implementation 
 
Phases Activity Conducted  Timeframe for Phase 
Recruitment 216 patients will be enrolled 
in the study. The protocol 
and how data and phases 
will be measured have been 
explained to the NP. 
 
 2 months. The first 2 months. Starting at 
the day the medication is written the 
patient goes on the list. 
Protocol implementation The patients will be 
identified as not picking up 
the medication and will be 
called and protocol applied.  
 Day 14 of each patient not picking up 
medication. 
This will run 60 days for each patient. 
Starting at the first day of medication 
prescription. Action by NP starts at day 
14. 
 
Data collection Telephone outreach tool 
will be applied.  
 This will run for 60 days for each patient 
starting at the first day of the 
prescription. 
 
Data analysis The outcome of the 
telephone encounters is 
applied and data were all 
collected.  
 
 Two weeks after data collection phase 
ended 
Evaluation The results will be reposted 
and all actions are evaluated 
 This will take two weeks to begin at the 
end of the data collection phase. 
Note.  The shortest possible time would be three months and longest time would be five months depending 
on the rate the patients picked up their medication. 
 
 All patients with a new prescription for a bisphosphonate were eligible to be 
enrolled.  Both men and women over the age of 55 years with a new prescription for a 
bisphosphonate were included.  This age of 55 and older was chosen because it was 
directly comparable to the Reynolds et al. (2013) article that discovered the problem of 
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PNA at the facility.  The only difference was men were also included in this study since 
the Reynolds et al. study included only women. 
 Bisphosphonates used in the study were Alendronate, Residronate, and 
Ibandronate.  The NP could see in the computer system the prescription and the 
medication prescribed.  However, they were marked only as bisphosphonate for the sake 
of this study.  All prescription orders were placed electronically so all prescribed 
mediation data were captured in the system electronically.  The data were stored in the 
organization’s pharmacy information system (PIMS) and also housed in the clarity data 
warehouse (CDW).  The medication prescription information was updated once daily and 
downloaded into the system.  Patient information data were also downloaded to the 
disease management registry for all patients in the facility’s pharmacy.  These systems 
interfaced with the disease management registries through the existing electronic medical 
record (EMR).  These interfaces allowed access to secure patient data of all new 
prescriptions for a bisphosphonate and whether a prescription order was picked up.  
Additionally, if orders were discontinued, cancelled, or changed by the prescriber, or the 
patient was terminated as a member, this was also noted in the system.  No prescriptions 
for bisphosphonates were written on paper.  The name of medication might have been 
populated but for this study, it was yes or no if the patient had a prescription for a 
bisphosphonate.  There was nothing to collect other than the NP acknowledged looking at 
this information and the call was placed to the patient during the appropriate period of 
time such as 14 days, 30, and 45 days.  The NP communicated with the researcher on a 





 The mean was calculated to determine the average age and average time interval 
the prescription was either picked up or not from the pharmacy.  The statistical analysis 
determined the interpretation of results and showed whether or not the goal was met.  
Statistical significance of and differences were determined. 
 Absolute risk reduction (ARR) is also called risk difference (RD).  Absolute risk 
is a very accurate way of presenting research results and help with decision-making.  In 
this example, the ARR of 6% equated to a relative risk reduction of 20%.  This meant 
that if 100 patients were treated, six would be having PNA to see a 20% reduction in the 
group.  Relative risk reduction (RRR) tells how much the treatment reduced the risk of 
bad outcomes of one person relative to the control group who did not have the treatment.  
The relative risk included everyone in the intervention group as compared to the control 
group. 
 Power analysis was necessary to determine whether the sample size selected was 
adequate.  In this case, a power analysis determined it would be necessary to have 216 
patients to represent a sample size that could be generalizable to the population.  The 
sample size and findings were designed to be statistically and clinically significant in 
order to be representative and show an improvement in the PNA rate, which was the goal 
of the program.  It was decided to run the study for two to three months to have enough 
patients because men were included in the study. 
 The Reynolds et al. (2013) study was used as a benchmark because it showed the 
incidence of occurrence in this study population to be 29.3%.  The data were useful 
because they were selected and used from the same population.  It was decided by the 
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research team that data collection for the span of two months would be adequate in 
generating the sample size needed to show statistical significance (n = 216).   
Data Collection Method 
 The data collection method with the use of this tool was through an interactive 
website that interfaced with the clarity warehouse wherein patient data were updated on a 
daily basis.  Most of the data were already stored within the EMR.  The NP collected data 
from the telephone encounters. 
Measures/Instruments  
 The measurements were taken and recorded by the NP into the Knowledge 
Builder Tool (KBT) embedded into the disease management registry.  All patients with a 
new prescription for a bisphosphonate were included in the study (n = 216) and the rate 
of PNA was measured after 60 days of patients not picking up their prescription. 
Variables Measured 
 
 A dependent variable depends on the independent variables.  In this case, the 
dependent variables were medication adherence and primary mediation non adherence.  
An independent variable is a variable that has an effect on the outcome.  Its value 
determines the value of other variables.  For example, it stands alone and is not changed 
by the other variables being measured.  An independent variable causes some kind of 
change in the other variables, such as dependent variables.  Six independent variables 
were identified in this study. The following variables were not collected by the NP since 
they are already in the in the KBT to assist the NP with information if needed and to help 
the NP determine that the patient was eligible for the program.  They were analyzed at 
the end of the study to report on the characteristics of the patient who was PNA versus 
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adherent to bisphosphonate therapy.  The data added value to the analysis of the results.  
It was important to understand the characteristics of the patient who is adherent versus 
primary non-adherent. 
 Age.  The age of the target population was set at 55 and older.  Age was measured 
in years and months.  The reason to use age and 55 or older in this study was to make the 
data more comparable; the number 55 was selected mainly in an effort to improve the 
rate of PNA.  The Reynolds et al. (2013) article found that age as a characteristic affected 
adherence risk and was used as a predictive variable.  The more closely their 
characteristic could be matched with our study population, the more significant the 
findings.  
 Gender.  This study population included men and women.  Men and women were 
selected because not much is known in the literature about men; this population has been 
historically underserved with osteoporosis diagnosis and treatment.  The population size 
was large enough so women could be directly compared to women in the comparative 
study with Reynolds and colleagues (2013).  Then our own women data could be 
compared internally with our male data to gain more knowledge and insight into men 
being characteristically more, less, or the same as women when compared in this setting. 
 Characteristic of prescriber: Nurse practitioner or primary care provider.  
Characteristics of the prescriber were assessed and compared to similar characteristics in 
the Reynolds et al. (2013) study.  It was thought that PNA could be predicted when 
certain characteristics of the prescriber were known.  In this study, only the characteristic 
of whether it was the NP care manager or the PCP who generated the prescription was 
collected and compared since these data were comparable.  For example, if the 
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prescription was written by the NP care manager, then the patient would have received 
program interventions such as education and face-to face-counselling with the NP that 
might not have occurred if the prescription was not written by the NP.  This factor was 
not as well controlled when the prescription was not ordered by the care manager.  
Medication teaching might vary from provider to provider if not implemented from 
within the program protocols, guidelines, and policies.  The NP did not collect these data 
as discussed earlier.  It was important to see if there were similarities related to the 
characteristics of the prescriber and patients who had PNA or were adherent. 
Summary 
 In summary, this capstone project implemented a protocol for which outcomes 
were measured to determine its effectiveness in addressing the problem of medication 
adherence in patients with osteoporosis.  This project was a population based study (n = 
216) that implemented an information based tool to reduce the rate of PNA by 20% from 
the current rate seen in this population.  The study was a prospective, observational 
analysis and includes all out-patient men and women in the program age 55 and older 
with a first time prescription for bisphosphonates.   
 The evidence-based telephone outreach protocol was fed by the KBT to provide 
the NP with a list of patients who needed a call.  The protocol was implemented by the 
NP as part of an existing osteoporosis disease management program (ODM).  Statistical 
analyses calculated and measured the variables, compared them to each other, and then 
determined whether or not the use of the tool was the reason for meeting the goal of a 









STUDY EVALUATION PLAN 
 
 
 This was a prospective, observational study conducted in a health maintenance 
organization (HMO) in southern California that measured the effectiveness of the use of a 
telephone protocol on the primary non-adherence (PNA) rate for bisphosphonates.  This 
study hypothesized that the intervention of a disease management program NP care 
manager who used a telephone outreach information technology (IT)-based tool on a 
population of patients with a first time prescription for a bisphosphonate would have an 
effect on improving the primary non adherence (PNA) rate.  A total of 216 male and 
female patients enrolled in the study who were 55 years or older.   
 This intervention was completed by using a computer program known to the 
organization as the Knowledge Builder Tool (KBT).  The KBT was used to capture  
patient data including new prescriptions and tracked those prescriptions for patients who 
did not pick up their new prescription bisphosphonate medication during a period of 60 
days.  In this study, at 14 days, an intervention in the form of a telephone outreach 
encounter was performed by the NP care manager of the fracture liaison program.  The 
following paragraphs describe details of how this study was evaluated, what evidence-
based measures were applied to the plan, what instruments or measures were used for 
each objective, and what method of analysis was used to measure each objective.  The 
variable of patients who picked up their medications prior to 14 days and then from 14 
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days to 60 days was tracked and compared to determine if a statistical significance 
occurred as a result of the program action and not purely by chance.. 
 Searching for patient data is very time consuming for the NP and not a cost-
efficient way for a provider to spend time (Akesson et al., 2013).  Without an 
appropriately integrated system in place, the NP could spend valuable program time 
searching for data to generate appointments and to communicate with the patients.  The 
KBT assisted with this by generating patient information to the NP on a daily basis.  This 
time saving feature allowed the NP to receive the list of patients with whom she could 
intervene related to their PNA actions in a timely and accurate manner. 
 The NP started this study on December 8, 2014 following Institutional Review 
Board (IRB) approval from the University of Northern Colorado.  The study 
implemented a protocol in the form of a telephone outreach tool and evaluated the 
effectiveness of the protocol on primary non-adherence (PNA) of patients with 
osteoporosis over a two month period.  
Exclusion Criteria 
 Patients were excluded from the study if they  
• were younger than 55 years of age 
• had chronic kidney disease (CKD) 4, 5, or were on dialysis 
• had a history of a previous prescription for a bisphosphonate that was picked 
up 
• did not have a current organization membership or current pharmacy benefit 
• had filled their prescription in an outside pharmacy 
• had the medication discontinued or placed on hold 
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• had allergies to bisphosphonate medication 
• had any medical contraindication to taking a bisphosphonate 
• died or lost eligibility for the organization membership at any time. 
Measureable Objectives 
 Two objectives were identified in this study: 
1. To develop and test a protocol to identify patients with osteoporosis or at 
risk for hip fracture with a new prescription for a bisphosphonate who had 
not picked up their medication from the pharmacy. 
2. To lower the primary non–adherence rate to bisphosphonate medication by 
20%. 
 To meet the first objective, the Doctor of Nursing Practice (DNP) student wrote a 
protocol for telephone outreach in collaboration with the organization leaders to improve the 
incidence of primary non-adherence to a bisphosphonate that was shown to be a prior 
problem in this population (see Appendix F for protocol).  As the protocol stated, non-
adherent patients were called at increments of 14, 28, and 45 days.  They were considered 
to be PNA at 60 days. 
 The telephone outreach protocol was used by the NP to apply and to meet the 
objectives.  The computer sifted through patient data and sent the NP a list of patients for 
whom she could apply the telephone outreach tool.  The DNP student researcher closely 
monitored the NP’s activities and analyzed the performance of the NP in addressing primary 
non–adherence (PNA) by using the protocol.  The NP met with the DNP student researcher 
and the physician advisor on a weekly basis for approximately 20 minutes for a total of 26 
meetings.  The purpose of all 26 meetings was to verify that all patients were being called on 
time, which patients were to be continued in to the next week, and that all steps of the 
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protocol were being followed properly.  At the end of each week, the physician advisor and 
DNP researcher had a telephone meeting to verify patients on the list and who were to be 
continued into the next week.   
 There was no deviation to the study or the protocol at any time.  If steps were not 
being followed at any time, adjustments in the form, clarification of which patients were still 
on the list, and verification that the intake forms were being filled out on time for each call 
made were discussed.  If a message was left, the intake form was filled out indicating that the 
patient was not spoken to but received a reminder message on the answering machine.   
 The second objective was to lower the primary non–adherence (PNA) rate to 
bisphosphonate medication by at least 20%.  The rate of PNA was depicted as a 
percentage and was compared to the baseline PNA rate of 29.5%.  Microsoft Excel 
Statistical Tools® was used to determine the rates and percentages that were compared in 
this study. 
Evidence-based Measures Applied to the 
Evaluation Plan 
 
 The theory of planned behavior (TPB) was used as a theoretical basis to change 
both the NP’s practice behavior and the patients’ behavior to create a new intention to 
perform the functions in order to improve PNA.  Clinical significance using Chi square 
analysis (p value) was determined.  Each independent variable was evaluated and 
compared for adherence and non-adherence (PNA) properties and their clinical 
significance was determined.   The connection to the protocol being responsible for 
making the change was evidenced by patients’ responses to questions during the 
telephone interview and pharmacy data indicating whether or not the patient picked up 
the medication after the phone calls were made. 
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 Effective program evaluation is a systematic way to improve actions and monitor 
what has been accomplished.  In analyzing and using data to examine the effectiveness 
and efficiency of any program, it is important to include a process for continuous quality 
improvement to monitor progress and outcomes.  The following is a framework designed 
to guide health professionals in the process of program evaluation; specifically, this 
framework was used in this project to evaluate the telephone outreach protocol.  This 
evaluation tool was developed by the Centers for Disease Control (2010) and is 
comprised of six steps that were used to evaluate the program’s effectiveness (see Figure 
4). 
1. Engage stakeholders.  The stakeholders were all involved in the protocol 
development.  They attended frequent face to face meetings and had an 
opportunity to give their input.  The identified stakeholders in this project 
were (a) the DNP student researcher, (b) the MD champion, (c) the HMO 
administration, (d) HMO pharmacists, (e) HMO Information Technology 
data analysts, (f) Disease Management Program staff, and (g) the patients. 
2. Describe the program.  The program is part of a fracture liaison program 
(FLS) and was designed to improve the rate of primary non-adherence to a 
bisphosphonate medication.  The NP coordinated a telephone outreach 
service to record patient responses as to the reason they had not picked up 
their medication within the allotted 60 days.  The NP called each patient on 
the list sent to her by a computer system that identified patients who had not 
picked up their medication.  The NP followed a telephone outreach protocol 
and contacted the patients.  The goal of the study was to have the patients 
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develop an intention to pick up the medication.  Using principles of theory 
of planned behavior, the NP acted as a change agent to have patients pick up 
their medication to patients who prior to the intervention did not pick up 
their medication. 
3. Focus on the evaluation design.  The focus of this design was to identify the 
factors that led to the patient not picking up the medication.  The goal of the 
NP was to make the patient more aware of the fact that he/she had not 
picked up his/her medication to achieve self-efficacy 
4. Gather credible evidence.  The literature review discussed the credible and 
evidence-based measures used in the paper.  Evidence generated by this 
study was in the form of data collected during the phone call that was 
collected, analyzed, and compared. 
5. Justify conclusions.  Proactive program design coordinated by NP using IT 
tools was used as an effective method to reduce PNA. 
6. Ensure use and share lessons learned.  There were desirable actions that 
would lead to an improvement in PNA.  Lessons learned from this study 






Figure 4.  Framework for program evaluation. Source: CDC (1999). 
 
 
Evaluation of Plan for Dissemination 
of Findings 
 The findings were disseminated within the organization prior to the roll out at all 
remaining 12 medical centers in southern California.  The plan was to publish the 
highlights and the results of this program with the University of Northern Colorado as 
well as in a selected medical journal so the results and knowledge gained from this study 
could be accessed accurately by the medical community. 
Evaluation of Nurse Practitioner Beliefs 
About the Theory of Planned Behavior 
 
 The theory of planned behavior (TPB) is based on Bandura’s (1977) theory of 
self-efficacy.  The NP was given information and trained related to self-efficacy and the 
importance of TPB to this study.  The concepts of TPB such as normative, subjective, and 
control beliefs were presented to the NP.  The Healthy Bones NP’s beliefs and training 
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were evaluated by a questionnaire (see Appendix E).  She was asked a series of questions 
regarding attitudes and beliefs related to the application of the TPB on the population of 
patients in the study in order obtain baseline information of her beliefs before and after 
she was exposed to the study information. 
Measurement and Evaluation of Patient 
and Provider Behavioral Intention and 
Behavior Change 
 
 The NP enhanced communication with the patient and built trust and rapport 
through the telephone conversations (Rogers, 2003).  In this study, the NP assessed, 
identified, and determined that change was needed in the patient’s behavior.  This was 
evidenced by whether or not the patient picked up his/her bisphosphonate medication 
from the pharmacy on time.  The NP utilized her skills in conducting an informational 
exchange of information with the patient in the form of a guided telephone call that 
helped guide patient decisions (Rogers, 2003).  After this step, intention in the patients 
was developed that translated into a new behavior. This transition to independence and 
change in beliefs and behaviors was due to the intervention and was measured by asking 
the patient a series of questions during the telephone interview (Morisky et al., 2008).   
To be an effective change agent, it was helpful that the NP believed strongly in what she 
was doing and that her actions led to an improvement in the patients’ outcomes.  For this 
purpose, the NP’s beliefs were measured on a Likert scale in the form of a questionnaire 






Evaluation of Ongoing Study  
Participation 
  
 On a weekly basis, the NP, DNP researcher, and physician advisor evaluated 
whether or not the data collection forms were being completed and helped to resolve 
problems; none were identified (see Appendix I for NP Intake Form).  The results of 
these meetings were summarized and recorded to insure that the protocol was being 
implemented appropriately with each patient enrolled in the study. 
Measurement of Patient Behavior  
Intention, Behavior Change, and 
Measurement and Evaluation of  
Outcomes 
 
 This study was based on the premise that the patient would develop a change in 
intention after receiving the telephone call and then change behavior as the result.  This 
change was measured as evidenced by the outcomes seen in the responses of the patients 
who were called.  The data collected were compared to show whether or not they picked 
up the medication after they received a reminder call.  If the patient was unable to be 
contacted, this was noted in the results of how many patients were not actually spoken to 
(see Appendix I) but were left messages by the NP.  Data collection sheets were used by 
the NP to collect data during each telephone call (see Appendix I). 
Additional Necessary Resources 
 The statistical tools used in this study consisted of an initial power analysis to 
determine the number of patients needed to determine statistical significance.  In this 
case, the number of patients enrolled in the population was 216.  A Chi square analysis 
was used to determine statistical significance of each variable.  The descriptive statistics 
used were the percentage of patients who were adherent versus the number of patients 
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who were primary non adherent (PNA).  The percentage of adherent patients was 
compared to the percentage of PNA patients.  These two groups were comparable 
because they all received the same intervention and all met the requirements for study 
inclusion.  The formula used was as follows: 
# of prescriptions picked up/total patients in the study 
PNA = 1- adherence. 
For example, in the Reynolds et al (2013) study, PNA equaled 1-0.71, which was 29.5% 
and 70.5% adherence rates.  The same descriptive statistics formulas were used in this 
study.  In this study, PNA + adherence =1 or 100%.  Data analysts from the HMO’s 
division of research validated that all results were calculated accurately. 
Summary 
 This protocol was evidence-based and used an existing theoretical framework 
based on the belief of changing behavior by creating intention.  The protocol used the NP 
and the computer to make sure there were no disparities in the way patients were treated. 
All patients in the study who did not pick up their medications at 14 days received  
telephone calls that asked each patient why he/she had not picked up his/her medication.  
Lastly, the data collected and analyzed showed results as a percentage and were 
compared to the previous rate of 29.5%, which reflected what existed in the program 
when no active steps were in place to reduce PNA, i.e., a protocol.  It was hoped this 
protocol could be replicated at all of the medical centers within the health plan in which 













RESULTS AND OUTCOMES 
 
 
 This capstone project evaluated the implementation of a newly developed 
protocol designed to improve the primary non-adherence (PNA) rate in men and women 
55 years of age and older with a first time prescription for a bisphosphonate.  The goal 
was to improve patient outcomes related to medication adherence by changing his/her 
behavior to pick up his/her medication from the pharmacy and to answer the following 
research question: 
 Q1 Will a telephone outreach protocol based on the theory of planned  
behavior (TPB) be effective in lowering the primary non-adherence rate 
(PNA) to bisphosphonate medication by 20% in a large Health 
Maintenance Organization (HMO)? 
 
Objectives of the Study 
 There were two objectives in this study: 
1. Develop and implement a protocol to target patients diagnosed with or at 
risk for osteoporosis and hip fracture who had not picked up their 
bisphosphonate medication from the pharmacy within 60 days--primary 
non-adherence (PNA). 
 This objective was met as evidenced by the protocol implemented in this study. 
The protocol identified the patients at risk, established the timeline, and was based on 
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questions in a theoretical framework (see Appendix F for an example of the telephone 
outreach protocol tool). 
2. Decrease the current rate of PNA by at least 20% from the identified rate of  
29.5%.  The current rate of 29.5% of PNA to bisphosphonate was decreased 
by 26.3% to 3.2%.  At 14 days during the study, the adherence rate was 
87.5% prior to patients receiving a phone call.  The PNA rate had been 
reduced to 12.5%.  This result is further discussed in Chapter V.  The results 
showed an overall 26.4% absolute reduction and an 89.2% relative 
reduction.  The goal of a 20% reduction was exceeded. 
Study Population 
Initially, 224 patients were identified as having a new prescription for a 
bisphosphonate and then screened for inclusion into the study.  Of the 224 patients, eight 
people were excluded, leaving 216 patients who were enrolled and completed the study 
(see Table 2 for exclusions).  Of the 216 patients, 168 were women (78%) and 48 were 
men (22%).  The age range of participants was 55-95 years old with an average age of 
70.8 years; the standard deviation was 8.9 years.  Race was not included in this analysis 
because we did not have accurate race data.   
 The timeframe for recruitment and enrollment of the 216 patients took one month.    
Inclusion criteria requirements were all patients 55 years of age and older--both men and 







 There were several reasons for participant exclusion.  Table 2 presents each 
reason, the number of patients in each group, and the percentage of each group.   
 
Table 2 
Reasons for Participant Exclusion 
Reason Number % 
Allergy to medication 1 12.5 
Chronic kidney disease 4/5 or dialysis* 1 12.5 
Outside pharmacy** 2 25.0 
Skilled nursing facility or hospice*** 2 25.0 
Medication discontinued 1 12.5 
Low Vitamin D or calcium on hold 1 12.5 
Total 8 100 
*A bisphosphonate is contraindicated in patients in chronic kidney disease. 
**Patient used an outside of the facility pharmacy so could not be tracked. 
***Patient is confined to home or another facility and would be given their medication by 
a nurse 
 
Implementation of the Telephone Protocol  
by the Nurse Practitioner 
 The study began after IRB approval was obtained (see Appendix A).  The NP was 
oriented to the telephone protocol and she agreed to implement this project on a voluntary 
basis.  She was administered a questionnaire that investigated her beliefs regarding the 
theory of planned behavior (TPB) at the beginning of the study and then two weeks into 
the implementation of the study.  The questionnaire used a 5-point Likert scale to respond 
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to the eight questions: 1—Strongly disagree, 2—Disagree, 3—Neither agree nor 
disagree, 4—Agree, and 5—Strongly agree.  The results of the questionnaire showed she 
scored all 5’s equaling 40.  The pre- and posttests revealed no change (see Appendix E). 
The NP answered the same on the pre- and posttests with a score of 5 on each question, 
showing she was in strong agreement with the study.  The purpose of this pre- and 
posttest was to serve as a proxy to determine she understood the TPB, agreed with the 
concept, and agreed to work with the researcher in conducting the study in addition to the 
consents. 
 The team consisting of the NP, DNP student researcher, and the medical advisor 
met on a weekly basis to discuss what had occurred that week and to see if there were any 
patients who still needed to be called.  The NP was given an opportunity to ask questions 
and make clarifications.  These meetings occurred during the enrollment period and 
throughout the calling period for three months when the study was officially closed--a 
total of 14 meetings.  The results of the meetings showed they were helpful in keeping 
the study on track.  The data collection ended earlier than planned because the last 
patients refused the medication.  In addition, the DNP student and the medical advisor 
met each week to discuss enrollment and review the data collected at the end of each 
week to see if there were any questions.   
 The following were highlights of the study plan and flow: 
1. The DNP student researcher, the medical advisor, and the NP care manager 
developed a protocol for this telephone outreach tool prior to the proposal 
acceptance of this study. 
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2. Telephone outreach was already included in the tasks of the NP care 
manager. 
3. Questions in the telephone protocol were developed based on self-efficacy 
and the theory of planned behavior (see Appendix F).   
4. After IRB approval was obtained (see Appendix A), patient enrollment 
began at the end of 2014. 
5. Weekly meetings occurred during the course of the enrollment and study 
period for 14 weeks at which point the study was officially closed. 
6. During the course of the meetings, the study flow was verified and all 
telephone calls were tracked. 
7. No problems occurred and any concerns were worked out in weekly 
meetings. 
8. Each week, the NP received a list of patients who had received a 
prescription for bisphosphonate medication 14 days prior and had not yet 
picked up their medication.  The NP implemented the protocol with these 
patients to impact PNA.   
9. The following unforeseen events occurred as a result of the study and are 
described in greater detail in Chapter V: 
a. Two patients picked up medication after 14 days but before the NP 
could call them. 
b. Six patients used pharmacies outside of their assigned pharmacy. 
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c. The pharmacy sometimes told patients to come back another day if 
they did not have stock or due to other pharmacy workflow concerns.  
This number was not known. 
The study officially ended 14 weeks after recruitment began when the protocol had been 
implemented on all patients enrolled in the study and/or all patients were 60 days out 
from receiving their bisphosphonate prescription.   
 In this study, NP beliefs about TPB were collected by a questionnaire both before 
and after the information about TPB was taught to her.  There were no changes from the 
first time it was completed to the second; she scored the same, all 5s, and her score was 
40 on both questionnaires.  She knew this study was being planned because of meetings 
during the planning phases with the organization.  She was very proactive in preparing 
for this study as she wanted to end up with good results and report success of the 
program. The NP’s beliefs were not being monitored other than to see that she 
understood the TPB and was in agreement with the belief of her ability to act as change 
agent in the study.  The questionnaire served as a proxy to determine she was on board 
with the study and she agreed with the concepts being presented. 
Telephone Outreach Protocol Tool 
   The telephone outreach protocol was a tool implemented on 27 patients who were 
not adherent in the first 14 days of receiving their bisphosphonate prescription.  At 14 
days after a patient in the study had not picked up his/her new prescription for a 
bisphosphonate, the NP implemented the protocol by placing a phone call to the patient.  
Twenty (74%) of 27 patients picked up their medication after receiving one or two phone 
calls from the NP who had applied the telephone outreach protocol.  Twenty-six calls 
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were made to 20 patients in this group for an average of 1.3 calls for each patient.  Two 
(10%) of these patients in the telephone outreach group picked up the medication after no 
calls. 
Adherent Group 
Overall, the adherence rate in the study was 96.8% (189 + 20 = 209 divided by 
216).  This represented the adherence rate of the telephone outreach group and non-
telephone outreach groups combined (see Tables 3, 4, and 6).  The groups were stratified 
by age showing results for adherence and PNA after one and two calls.  No one in the 
adherence group had three calls placed.  Two people who did not receive a call picked up 
the medication at 17 and 18 days.  Although they were included in the telephone call 
group, their reasons for not picking up the medications prior to 14 days were not 
captured.  The following is a breakdown of the calls in the telephone outreach adherent 
group: 10 (37%) patients received one call before becoming adherent, 8 (19%) received 
two calls before becoming adherent, and 2 (7%) received no call before becoming 






Adherence Rates Before and After Telephone Outreach Call 
Age Group Picked up Prior 










 N % N % N % N %  
55-59 18 94.7 1  5.3 0 0 0 0 19 
60-64 17 85.0 1  5.0 0 0 2 10.0 20 
65-69 60 80.0 10 13.3 4 5.3 1   1.3 75 
70-74 33 97.1 0  0.0 0 0 1   2.9 34 
75-79 23 92.0 1  4.0 1 4 0   0.0 25 
80-84 22 88.0 1  4.0 0 0 2   8.0 25 
85+ 16 88.9 1  5.6 0 0 1   5.6 18 






Descriptive Statistics of Telephone Outreach Protocol 
 Average 
Age 
Age Range SD N % 
 
Picked Up Not in Telephone 
Outreach Prior to Day 14 
70.94 55-93 8.9 189 87.5 
Picked Up in Telephone 
Outreach after Day 14 
 
69.25 
                               
 
55-95 8.3 20 9.3 
Picked Up Total 
 
70.80 55-95 8.9 209 96.8 
Primary Non-Adherent 72.90 61-88 10.4 7 3.2 
 
Overall 70.85 55-95 8.9 216 100 






Table 5   
Adherence of Patients   
Patient Characteristics N % Average 
Age 




       
Adherent With No 
Telephone Calls Prior to 
14 Days after Receiving 
Prescription 
 
189 87.5% 70.94 55-93 74 8.9 
Adherent  After 
Receiving 1 or 2 
Telephone Calls After 
Day 14 
 
20 9.3% 69.25 
 
55-95 75 8.3 
Adherent After Receiving 
1 Telephone Call After 
Day 14 
 
10 4.6% 69.25 55-95 75 8.9 
Adherent After Receiving 
2 Telephone Calls After 
Day 14 
 
8 3.7% 69.25 55-95 75 8.9 
Adherent after 0 calls 
after Day 14 
20 .9% 67 65-69 66 1.5 
 
Total Number of Patients 
















Total of Primary Non-
Adherent 
 
7 3.2 % 74.5 61-88 74 10.4 
All Patients In Study 216 100% 70.85 55-95 74 8.9 
 
 Table 6 shows a summarized version of days needed to pick up the call after one 
or two calls, if a message was left, or if the patient actually spoke with the patient.  A 
slight difference was noted; the average age in the group needing one call was 66.3 years 




Table 6  

















SD 2 messages 













On 1st call  
Message left 
















5.6yrs 0 0 0 0 0 0 0 0 








6.4yrs 0 7(27%) 0 3 0 10(10x1) 7(27%) 3(12%) 









6 0 2 0 6 16 (8x2) 2 (8%) 14(53%) 
3 0 0 0 0 0 0 0 0 0 0 0 0 0 














 Table 7 shows descriptive statistics of one call versus two calls to pick up the 
medication in the telephone outreach adherent group. 
 
Table 7 
One Call Versus Two Calls to Pick Up Medication in the Telephone Outreach Adherent 
Group 
 
Days N Average No. 




SD Men Women Average 
age 
    N % N %  
After First Call 10 2.7 2.1 2 20 8 80 66.3 
 
After Second Call 8 6.6 6.0 2 25 6 75 72 
 
No Calls Needed 2     2 10 73 
 
 
Primary Non-Adherent Group  
 The remaining 7 of the 27 patients (26%) did not up the medication after being 
called.  Four of the seven patients (57%) stated they did not know her and wanted to wait 
until they spoke with their prescribing doctor.  Two patients (29%) told the NP on the 
first call they forgot; on the second call, they stated they had changed their minds and did 
not want the medication due to fear of side effects.  One person (14%) who needed a 
phone call was not able to be reached by phone and then went on to be PNA after three 
messages were left by the NP.  Nine calls (35%) resulted in a conversation with the 
patient and 17 calls (65%) resulted in messages left.  Table 8 provides the origin of the 
prescription, reasons for not picking up the medication, whether or not the NP spoke to 




Reasons for Not Picking Up Medication 











1 NPCM 3 Unknown 0 3 
 
2 NPCM 2 Initially said forgot on 
first call; now refuses 
medication--worried 
about side effects 
 
1 1 
3 Other 2 Initially said forgot--now 
refused on second call.  
Worried about 
medication side effects 







4 Other 1 Refuses treatment--wants 
medication discontinued, 
has concerns about drug 
complications, and does 




5 Other 1 Refused--has concerns 
about side effects 
Refuses treatment – 
Discontinued--concerned 
about drug complications 
 
1 0 
6 Other 1 Refused--has concerns 
about side effects. 




7 Other 1 Refused--has concerns 














    11 
Note.  NPCM = Nurse Practitioner Case Manager   
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Characteristics of the Prescriber 
 Of the 216 patients in the study, 121 (56%) prescriptions were written by the NP 
care manager in the program.  Of these 121 patients, 14 needed one or two calls by the 
NP and 2 (1.7%) went on to be PNA; 105 (87%) picked up their meds in the NP 
prescription group prior to 14 days and were included in the overall study adherence 
group.  Being part of the HMO system, the patients see other physicians who might 
generate a prescription for a bisphosphonate and those patients might have been included 
in this study.  Although the Chi-square analysis was exactly at .054864 and not less than 
.05 for the NP writing the prescription and not the primary care provider (MD) or another 
outside prescriber, this result was not statistically significant although highly suggestive.   
It would be helpful to have the NP write the prescription and call and follow up with 
patients.   
 Ninety-five prescriptions were written by another provider other than the NP.  Of 
these 95 patients with prescriptions written by someone other than the program NP, five 
were in the PNA group and 84 (88.4%) picked up the medication within 14 days and did 
not require a phone call.  After 14 days, six (6.3%) patients required a phone call and of 
these patients, five went on to develop PNA (5.2%).  When they were called by the NP, 
several gave reasons such as they were afraid of side effects or wanted to talk to their 
doctor again.  Four patients stated they did not know the NP since she had not written the 
prescription; they wanted to speak to their prescribing doctor before they would take the 
medication so they refused to pick up the medication.  Table 9 provides the prescriber 
characteristics for non-adherent patients.  Figure 5 shows prescriptions by the nurse 
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practitioner versus other clinician for study telephone protocol primary non-adherent 
versus adherent groups.   
 
Table 9 
Prescriber Characteristics for Non-Adherent Patients 








Fear of side effects 






Other Fear of side effects 









         Figure 5.  Prescriptions by nurse practitioner versus other clinician for study telephone 






















 The first two columns in the chart represent all patients in the study.  In the 
telephone outreach group, the program NP wrote 121 and 95 prescriptions were written 
by another clinician.  Results showed that in the NP group, patients were more adherent 
and had fewer incidence of PNA than other clinicians.  Patients in the NP group appeared 
to respond better to the telephone outreach protocol than the prescriptions written for 
other clinicians although this was not found to be statistically significant possibly due to 
the small sample size. 
 Table 10 provides the number of prescriptions written by the nurse practitioner, 
the number of calls made, the reasons for not picking up the prescription, and messages 
left if no contact was made.  In the telephone outreach group, the program NP wrote 121 
prescriptions.  Five (35.7%) of 14 patients in the NP prescriber group answered more 
frequently that they forgot and the call served as a reminder.  Table 11 shows that 95 
prescriptions were written by another clinician; also show, is the number of calls made, 
the reason for not picking up the prescription, and messages left if no contact was made. 









Percent Reason for not picking 
up prior to 14 days 
Could not reach 
patient after 3 
messages left 
PNA  2 1.7 1 patient stated on 2nd 
call 1 message left 
&second call reached 
the patient .She stated 
initially forgot but now 
has decided not to take 




Picked up after 1 
or 2 calls 
18 11.5 Forgot stated will pick 
up within the week 
Calls or messages left 
served as a reminder 
for this group. 
 
0 
Picked up after no 
calls in telephone 
outreach group 
2 1.65 Patent was on call list 
but NP did not get a 
chance to call yet. Pt 




Picked up prior to 
14 days so did not 
need a call by NP 
 
105 87 N/A 0 





Table 11  
Prescriptions Written by Another Prescriber 
 Total 
Patients 
Percent Reason for not picking up prior 
to 14 days 
Could not reach 
patient after 3 
messages left 
PNA 5 5.2 4 patients wanted to speak to 
prescribing doctor first 




Picked up after 
1 or 2 calls 
6 6.3 2 patients forgot 
1 patient was out of the country 
3 patients were not contacted 
 
3 
Picked up prior 
to 14 days—did 
not need a call 
by NP 
 
84 88.4 N/A 0 




 Of the men and women in the study, 161 women (95.8%) picked up their 
medication within 60 days and all 48 men (100%) picked up their medication.  The data 
analysis showed the Chi square statistic of 2.067 did not reach significance in men versus 
women who picked up their medication.  The p value was .150519; thus, it was not 
significant at p < .05. 
 A total of 26 calls were made to 20 patients in the study; nine resulted in 
conversations with the NP and 17 resulted in a message left.  Men were more adherent 
than were women in picking up after one message was left: 16 (80%) women vs 4 (20%)  
men in the adherent group. The PNA group consisted totally of women. 
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 The current rate of 29.5% of PNA to bisphosphonate was decreased by 26.3% and 
the rate of PNA was reduced from 29.5% to 3.2%.  This was a 26.4% absolute reduction 
and an 89.2% relative reduction.  The goal of a 20% reduction was exceeded; thus, the 
two objectives of the study were met. 
 Figure 6 presents the results from the statistical analyses conducted on the above 
















 The goal of any disease management program is to prevent disease from 
worsening.  The NP-led clinic in this study allowed for patients who had not picked up 
their bisphosphonate medication to be identified and tracked more easily than not having 
a dedicated person responsible for doing this.  The results of this paper showed the 
objectives in this study were met.  The objectives fit into three levels or categories of 
non-adherence: the systems level, the patient level, and the provider level.  In addition, 
the following research question is discussed: 
Q1 Will a telephone outreach protocol based on the theory of planned  
behavior (TPB) be effective in lowering the primary non-adherence rate 
(PNA) to bisphosphonate medication by 20% in a large Health 
Maintenance Organization (HMO)? 
 
 The ultimate goal of the program was to lower the PNA rate by targeting those 
patients who had not picked up their medication and by changing their behavior to 
develop an intention to pick up their medication.  The evidence gathered showed the 
benefit gained by using the telephone outreach protocol to assist patients in being 
adherent in taking their medication.  The study results in this paper showed success in 






 At the systems level in this study, a disease management program setting had the 
advantage over other settings because it used a dedicated NP and patients were identified 
by using the Knowledge Builder Tool (KBT).  The KBT systematically identified non-
adherent patients and sent the NP a list of patients who needed a phone call after 14 days 
of not picking up the bisphosphonate medication.  The telephone outreach tool was used 
to implement the prevention intervention strategy to improve patient outcomes.  A major 
component of the success of this program was it gave the NP the ability to monitor the 
treatment of patients using the computer system to follow up and track patient responses.  
Using the disease management program telephone outreach protocol allowed the NP to 
use a systematic approach when identifying and closing the care gap of PNA.  The 
systematic approach utilized by the NP insured the intervention was performed uniformly 
with each patient receiving the same intervention.  
 However, it is unclear whether the success of the study was due to the protocol 
itself or the message having an effect on patient change in behavior.  The integration of 
information in this system allowed the NP to focus on calling the patients since the 
computer conducted the case finding for her.  She applied the protocol to patients who 
had not yet picked up their medication at 14, 28, and 45 days.  Patients were considered 
to be PNA after day 60.  If patients in the telephone outreach group did not answer when 
the NP called, she left a message to remind the patient to pick up their medication or to 
call the department if they had questions.  Of the 27 patients in the telephone outreach 
group, 20 picked up their medication (74%) following a total of 26 reminder calls.  The 
other seven patients went on to PNA (26%), yielding a PNA rate of 3.2% for all patients 
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in the study.  Of the 26 reminder calls made, 17 resulted in messages left and nine calls 
ended in a conversation with the patient in which the protocol was applied.  In the 
adherent group, 23% of the patients never spoke to the NP and had only messages left 
prior to picking up the medication.  The messages left might have been be just as 
effective in achieving the desired change in behavior as the telephone call or the protocol. 
Limited data in this area preclude drawing conclusions and further study in this area is 
indicated.  In the PNA group (7/27= 25.9%), 11 calls were made to seven patients 
resulting in six (55%) conversations with patients and five (45%) messages left.  One 
person in the PNA group was not reached and three messages were left.  For these 
patients, a message was not effective in changing behavior.  In the PNA group, five of the 
seven (71%) received their prescription from a prescriber other than the NPCM and only 
two (29%) received their prescriptions from the NPCM.  The differences between those 
who received the prescription from the NPCM and those who received it from another 
prescriber were not statistically significant.  Comments made by the patients who 
answered that they refused to pick up the medication before making an appointment to 
speak with their prescribing doctor suggested clinical differences as they did not pick up 
the medication prior to 60 days of the prescription after speaking to the NP.  
 The findings suggested that had the NP been the prescribing clinician on the 
phone with the patient, these patients might have had their questions answered and might 
have been persuaded to pick up the medication.  Having the prescribing NP call the 
patient might be effective as evidenced by four PNA patients’ comments with 
prescriptions written by other than the NP coordinator.  These patients stated they needed 
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to speak with the prescriber again to have questions answered and clarification of side 
effects before they decided to pick up the medication. 
Provider Level 
 Overall, this study was successful--the rate of primary non-adherence (PNA) was 
lowered, indicating improvement in outcomes for patients.  The provider NPCM played a 
large role in the success of this study.  The rate of PNA went from 29.5% to 12.5% in the 
first two weeks of the study.  After the first two weeks, a 14 day non-adherence that 
began at 87.5% improved to 96.8% by using the telephone outreach tool and leaving 
telephone messages  reminding patients to pick up their bisphosphonate medication.  The 
NP’s behavior and communication with patients might have been impacted by the fact 
she knew she was being watched/studied (Hawthorne effect; McCambridge, Wilton, & 
Elbourne, 2014).  This could have been a potential threat to the validity of the study.   
 Other departments were also aware the study was taking place in the program and 
prescribing patterns and PNA were being studied at that facility.  The effect of the 
expectation of others on changing the NP’s behavior as outlined in TPB could also have 
been impacted by the Hawthorne effect (McCambridge et al., 2014) and thus a threat to 
validity.  Whether or not the patient’s behavior was impacted by the Hawthorne effect 
should be considered as well.  However, there were inefficient data to say this happened 
and should be investigated further to prove this theory.  The patients were blinded to the 
study so the Hawthorne effect was not a factor in their decisions to change.  Since the 
bisphosphonate was a normal part of their healthcare, they did not have to sign consents 
and were not told their behavior with regard to compliance was being tracked.  However, 
the TPB may have had an effect on them--the telephone calls and messages made the 
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patients aware of an expectation of the organization was they would pick up their 
medication.  Knowledge of this expectation could have affected them to develop an 
intention and carry out the behavior being asked of them. 
 The TPB states that someone’s behavior might be changed when he/she knows a 
behavior is expected of them by others.  The TPB was applied here with the protocol but 
might also apply in the cases where the NP did not ask the questions, i.e., the telephone 
messages left.  In 50% of the patient responses in the PNA group, they indicated they had 
more questions.  The telephone call served as a way for the NP to answer those questions.  
The NP’s ability to alleviate patients’ fear of side effects or answer questions about 
concerns could increase patients’ feelings of confidence about taking the medication 
(social/normative).  Additionally, the TPB states that people change their behavior based 
on having the belief they are doing the best thing for themselves.  Believing one is doing 
the best thing for oneself, doing what  is expected by others, and the perception of control 
to perform the action are three principles of TPB that must be present for behavior 
change to occur.  The telephone call might serve as an impetus to having those three 
concepts present and assist with the behavior change in this way.   
 Table 5 showed that 8 (40%) of 20 patients who needed a telephone call had one 
or two messages left and then picked up the medication without speaking to the NP.  This 
showed promise that a telephone message might be just as effective as a conversation in 
getting patients to pick up the medication.  The message might serve as a reminder and 
the patient has no questions or reluctance to pick up the medication.  However, in the 
cases of messages left, there was no patient feedback to be confident of the purpose the 
messages served.  In other words, not enough data were available to determine how 
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effective a message was compared with a conversation using the protocol.  Either way, 
the time to pick up the medication by patients was reduced after the phone calls were 
placed.  
 The results showed some kind of action was triggered after the call or message 
when previous to the call, there was no patient action.  The average time to pick up the 
medication after the first phone call was 2.7 days; prior to the NP action, the patient had 
not picked up the medication after 14 days of the prescription being written.  Just the call 
itself might have called upon the TPB--the patient, whether speaking to the NP or upon 
hearing the message, would realize the organization was expecting an action from 
him/her to pick up the medication.  Since no data were collected on 17 (65%) of the calls  
resulting in messages left and 30% of those patients never actually spoke to the NP,  there 
is no way to determine the degree of value the messages served when compared to actual 
phone conversations. 
Patient Level 
 At the patient level, patients have a responsibility to take their medication and to 
work with their healthcare provider to meet their healthcare needs—in this case, lowering 
their PNA rate.  Patient responses on telephone calls were recorded to know the reasons 
why the patients had not picked up their bisphosphonate medication.  All of the patients 
who were PNA were women.  This was shown to be statistically insignificant.  Perhaps, it 
could be inferred that men might be at less risk for non-adherence when previously they 
were thought to be more non-adherent than women. 
 In this study, the patients participated by responding to the phone calls and 
answered questions why they had not picked up their medication prior to 14 days.  In four 
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out of seven PNA patient responses to the NP on the phone, the patients stated they felt 
more comfortable talking to the person who prescribed the medication and they needed to 
talk to their doctor before deciding to pick up their medication because they had more 
questions.  Since the patients stated they did not know the NP caller, they did not feel 
comfortable making a decision on the phone with her that day.  Having the prescriber of 
the medication talk to the patients as follow up when they do not pick up their medication 
might be effective.  If the caller and the prescriber were one and the same, this barrier to 
the patient picking up the medication could have been resolved with the phone call.  This 
substantiated the argument that the program NP should write the prescriptions for a 
bisphosphonate as part of the program and then call patients who did not pick it up.  If 
contact was not made, it was speculated that a telephone message might be just as 
effective as actually speaking with the patient.  By responding to the calls, the patients 
assisted the study in meeting the goal of lowering the PNA rate.   
 A majority of the responses by patients were “I forgot” (50%); the telephone 
outreach calls might have served as a reminder that taking the medication was important 
to the care provider, which fits into the concept in the TPB.  The telephone outreach call 
could prevent the need for an additional appointment, which could be translated into cost 
savings for the patient and the HMO organization.  In the private sector, the fee-for- 
service period of the past is slowly being replaced global billing or one fee for a diagnosis 
for a set period of time.  It would make sense to conserve face-to-face visits for patients 
who really need a visit that cannot be achieved by a phone call or virtual visit.  Although 
billing and payment were outside of the scope of this study, the HMO does not collect 
any additional revenue for face-to-face visits that could easily be handled remotely. 
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Timetable to Completion 
 Enrollment began as soon as the University of Northern Colorado’s Institutional 
Review Board (IRB) approval was obtained.  Inclusion and exclusion criteria of enrolled 
patients was discussed and verified by the medical advisor that each person met criteria 
for inclusion/exclusion.  The medical advisor and the team met with the Information 
Technology Department (IT) to have all patients assigned a unique identifying number so 
data presented to the student researcher were blinded from any identifying factors.  The 
NP started to call patients who met the two week prescription date from November 24, 
2014 and applied the protocol to patients meeting the incremental dates of not picking up 
their medication from the pharmacy at 14 days and beyond.  Weekly meetings were 
conducted to troubleshoot and to monitor the course of the study. 
 Overall, the study flowed well according to the planned timeline.  The enrollment 
and actual timeline of enrollment took one month; it was predicted to take two months. 
When the study began, the providers were prepared to write necessary prescription and 
knew that they were being studied.  This might have had some effect on the faster rate of 
enrollment.  
Work Flow Process/Project Activities 
 The workflow of the study involved the NP working within the disease 
management program.  She was given a list of patients to call with a new prescription for 
a bisphosphonate and then she used the telephone outreach protocol to call the patients at 
varied increments of time.  The NP was the key player in the success of this study.  She 
had a physician supervisor and the ability to order a referral to endocrinology services or 
to her physician champion for patients needing a specialty consult.  She was also the 
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primary person who collected the data for the study, which consisted of patient answers 
to questions from the telephone outreach protocol.  The call, conversation with the 
patient, and messages left did not vary in the information provided by the NP and would 
have had the same effect on the outcome. 
 The NP believed she was familiar with the self-efficacy theory (SET) and the 
TPB and decided to study these theories on her own as she wanted this program to be a 
success.  She volunteered to implement this protocol at her program site and had 
experience implementing other programs in the past.  She was very confident that change 
was possible and believed this study would succeed as was stated by her at one of the 
meetings while the study was being planned. 
 The NP called the patient at various intervals of time pre-determined in the 
protocol.  Using questions designed from the theory of planned behavior (TPB) and the 
domains of self-efficacy, the reasons for patient primary non adherence (PNA) and 
whether or not the patient changed his/her behavior and picked up his/her medication 
were recorded.  The protocol targeted patients with primary non-adherence to their 
bisphosphonate medication; the goal was to use the protocol to change the patients’ 
behavior to become adherent to the prescribed bisphosphonate.  Although this was a new 
tool and was not validated or tested prior to this study, previously published validated 
data were used in developing the questions (Ajzen, 1991; Morisky et al., 2009).  
However, 17 of the calls in the adherent group ended up with a message being left 23% 
of the time; the patients did not actually speak to the NP and picked up the medication 
after having two messages left by the NP.  This might have prompted the patients to pick 
up their medication because the call acted as a reminder, letting the patient know an 
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action was expected of them by their healthcare provider.  An assumption could be if the 
doctor or other healthcare provider thought it was important enough to call several times, 
then it must be important and must be taken seriously by the patient.  The concepts of 
TPB might be applied here even without the administration of the questions that state the 
person will change his/her behavior if the action (a) is believed to be beneficial, (b) 
behavior change is expected by others, and (c) the behavior is in the perceived control of 
the patient.  All three of these concepts might have occurred purely by the patient 
receiving a call or a message.  The expectation of a response by the patient was requested 
by the NP either during the telephone call or the telephone message that asked the patient 
to please pick up their medication prescription for a bisphosphonate from the pharmacy.  
The patients became aware this action was being monitored and was an expected and 
desired action by their doctor who was following up on this action. 
 According to Eisman et al. (2012), using a NP coordinator to make phone calls is 
a cost effective way to manage care gaps.  As a normal part of her daily activities, the NP 
collected the data and communicated with the patients to get feedback that could be used 
to improve the goals.  Since telephone outreach was already an existing work function for 
her, the study did not add more work for her.  This study, as indicated by the program, 
sparked an interest in future research to evaluate whether or not a phone call might 
replace a clinic face-to-face visit to address PNA.  Although no time and cost studies 
were done in this study, the NP was able to call patients on the phone and save the time 
and staff it would take to conduct an office visit.  This might be both a time and cost 
effective way to close PNA care gaps and should be further investigated.    
115 
 
 Implementation of the telephone outreach program based on TPB was discussed 
as a plan to be added to the organization’s strategic goals and implemented organization 
wide given the favorable results of this study.  However, in cases where the NP did not 
speak to the patient directly, no feedback was obtained about the patient’s intention, 
leading to insufficient data to determine if the call or message were received by the 
patient in the manner intended or if the telephone outreach prompted a response by the 
patient.  It was assumed some change occurred because 23% of the patients picked up the 
medication within 2.7 days after the call; whereas prior to the call, no action had been 
taken to pick up the medication greater than 14 days. 
Recommendations and Implications for Practice 
 Primary non-adherence (PNA) has been discussed as being caused by failures at 
the patient, provider, or system levels.  Literature (Kastner & Straus, 2012) has shown 
that successful disease management programs all incorporate the fracture liaison service 
(FLS) model of care, telephonic outreach, electronic medical record (EMR), and 
integrated pharmacy systems.  To date, attempts have been made but no one has been 
able to integrate all needed components of this kind of program.  This statement gave rise 
to the need for further work and research. 
 The literature has shown that patients with a first time prescription for a 
bisphosphonate were not picking up their medications.  This problem sparked an interest 
to develop a system and protocol that could be applied to improve PNA.  Evidence-based 
guidelines were ineffective unless they were implemented and then translated into 
practice.  The implementation of an osteoporosis disease management program, 
especially if an electronic health record is used, could be an effective tool in lowering the 
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hip fracture rate.  Through the use of clinical practice guidelines and a staff trained with 
TBP, acceptance and implementation of such systems could facilitate changing current 
provider behaviors.  The literature did not clarify all factors concerning the reasons for 
PNA.  Confusion and no standardization of terms and definitions made describing the 
problems and solutions difficult to compare between studies.  This capstone project 
implemented this protocol for which outcomes were measured to determine its 
effectiveness in addressing the problem of medication adherence in patients with 
osteoporosis.  Once this program standardization is established, other researchers can 
build upon it instead of recreating and applying new terms to what has already been 
established. 
 The study by Reynolds et al. (2013) was used as a motivator and gave credibility 
for the need to implement this program.  As a result of this project and success of the 
program, the plan is to expand this program to all 13 medical centers in this organization 
and employ a NP-led clinic that could easily implement this protocol for patients who had 
not picked up their bisphosphonate medication.  The computer system is connected to all 
sites, centralizing patient chart information; pharmacy data are also connected and easily 
tracked.  An NP would follow the protocol with those patients who had not picked up 
their medication. 
 It is recommended that this protocol be adopted into practice and integrated into 
the organization’s strategic plan.  The philosophy of the organization is based on 
identifying and then preventing problems known as care gaps using a systems-based 
approach to close each care gap.  The FLS program has various strategic goals to meet 
concerning medication adherence; finding a solution to the problem of PNA could 
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become an internal strategic goal of the organization.  The NP at the facility would take a 
role in training NPs at the other 13 facilities where this protocol would be implemented. 
 Another recommendation would be to include having the disease management 
program NP work more closely with the pharmacy regarding patients who had not picked 
up their medications.  Mail orders might be adopted in the future to send prescription 
medications to patients who are unable to drive to the pharmacy to assure that patients 
receive the medication.  Additional action by pharmacists would help overcome at least 
one barrier to patients receiving their medication as they could encourage the patient to 
pick up all of their prescribed medications and send a note back to the prescriber letting 
them know when a patient has elected not to pick up all medications and when a 
medication has been unfilled for any prolonged period of time.  This information could 
serve as a future recommendation to include the telephone outreach tool and the 
pharmacy to close the care gap of PNA. 
 Although this program was implemented in a closed system, where the patients 
were all members of the health plan and all used the organization’s pharmacies, this type 
of program could be implemented in open systems as well.  Within any organization, the 
computer system would be able to interface with all of the departments and the patient 
medical record could be received in real time.  The HMO system exemplified in this 
organization might offer an advantage to private paying systems.  However, it is possible 
to implement this in any system where a dedicated person such as an NP could identify, 
risk stratify, coordinate the care of the osteoporosis patient, and implement the telephone 
outreach program to track patient compliance.  It is important that each program maintain 
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outcomes information about patients who pick up the medication versus patients who do 
not and then use quality measures to continue to improve upon the results. 
 The literature has shown it is necessary to use a systematic approach and a 
dedicated coordinator to close care gaps.  It is very time consuming for an NP to search 
data to generate appointments for patient encounters or to conduct program outreach 
operations.  Thus, the KBT could cut down tremendously on the amount of time needed 
to track patients.  Thousands of records could be sifted by the computer and an updated 
list generated on a daily basis, thus allowing the NP to work the list, organize time, and 
set priorities more efficiently. 
One recommendation for the future would be to automate calls.  Call automation 
in this organization is currently being performed for other reminders such as scheduling 
appointments or diagnostic tests when it is not necessary to speak directly to the patient.  
Automated telephone calls to remind patients they should pick their medication could be 
made in the voice of the prescriber.  By automating the calls, the NP’s schedule could be 
freed up to coordinate patient care and follow up needed, further improving time 
efficiency and saving money by not paying an employee make the calls.  The NP’s time 
could also be utilized to answer calls from patients who have questions and have the 
machine take a message for patients wishing a return call from their providers.  Further 
study should be conducted to assess cost effectiveness and cost savings gained from 
implementing this protocol, i.e., whether an automated call could be just as effective in 
lowering the incidence of PNA as the NP speaking directly to the patient.  
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 Using an NP as a care coordinator could further the opportunity to meet fracture 
reduction goals and improve the rate of PNA.  It would be interesting to repeat this study 
using more patients to see if differences noted were statistically significant.   
 In addition, it appeared that even without any action being taken, the PNA rate 
could be reduced by having a dedicated person write prescriptions, monitor patient 
activity in the program by making phone calls when necessary, and work a list provided 
by the computer.  In this study, only 37 calls were made, which made a significant 
difference in the outcome when compared to what was happening before the outreach 
was implemented.  On average, it took two calls to have a patient pick up their 
medication.  These 37 calls were successful in motivating 20 people to pick up their 
medication.  This left seven patients as PNA compared to the 64 patients (29.5%) seen as 
PNA prior to the reduction sparked by the outreach effort.  In this study design, the 
threshold to meet the reduction goal of this study was set at 50 (20%) people in order to 
reduce the PNA rate and meet goals.  Having as little as 50 people with PNA in this 
study, outcome would have acceptably met the objective of at least a 20% reduction in 
objective #2.  Instead, this expectation was exceeded and only seven patients were PNA. 
Barriers and Unintended Consequences 
 A few barriers and unintended consequences were encountered during the study.  
During the first week of the study, it was difficult to coordinate weekly meetings with the 
NP due to her availability but after that, a regularly established day of the week was 
scheduled without fail.  This weekly meeting was essential to the success of the program 
because it clarified communication and kept the study on track.  The communication 
went as planned as the study progressed.  Another perceived barrier quickly overcome 
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was the NP reported she could not reach some patients on the phone so she left voicemail 
messages.  This was accepted into the study and documented as an outcome.  Although 
the patients still picked up the medication 2.7 days sooner than prior to the call as 
compared to 10-14 days with no activity, it is not known what the outcome would have 
been if the patients had been reached by the NP.  Once the study organization was up to 
date on the timeline, the study actually flowed according to plan. 
 Several unintended consequences were encountered during the study.  The first 
was not all patients picked up their medications from the medical center pharmacy to 
which they were assigned.  For example, there were several instances when the patient, 
after having surgery for a hip fracture, stayed with family living in the area of another 
medical center--the prescription was at one facility but the prescription was picked up in 
another area, which delayed the patient from picking up the medication by a week or 
more.  This situation did not meet the criterion of an outside pharmacy because it was 
still within the organization’s pharmacy system and so was able to be tracked.  This issue 
was not addressed in this study but will be added to future department meetings.  There 
are plans for the pharmacy to be invited to a monthly meeting so possible solutions to this 
problem can be discussed and solutions provided.  This was outside the scope of this 
project but will be included in the organization’s strategic plan to improve the system and 
deal with pharmacy issues. 
 Another circumstance arose when a patient picked up the medication between 14 
and 21 days and might have picked it up prior to receiving the first phone call.  This 
patient was included in the call group but was also past the first two weeks by a couple of 
days and had not yet been called by the NP.  Upon chart review, whether or not the 
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patient had received a call was clarified, was listed in the results in the call group as zero 
calls, and adherent past 14 days.  If the patient had not received a call, it was noted that 
the patient was adherent upon his/her own accord and was not influenced by the call to 
pick up the medication.  Two patients met these criteria--they decided to pick up the 
medication at 17 and 18 days.  Although they were on the call list to be called by the NP, 
the NP had not yet called them and they picked up the medication without needing a call.  
This could be solved by establishing a more uniformly and systematic method of 
implementing timely phones calls.   
 Still another unforeseen circumstance came when the patients went to the 
pharmacy on the day the prescription was written and were told by the pharmacy to come 
back another day because the medication was not in stock, back ordered, or the line was 
too long and the patient could not wait.  Some patients stated they were not able to return 
the next day, thus delaying them in getting a ride back to the pharmacy on another day to 
pick up the medication if they did not drive.  This situation was discussed with the 
pharmacy director and the pharmacy has now started a mail order program and is keeping 
a larger shelf stock of this particular medication to avoid these problems from re-
occurring in the future. 
 Lastly, the actual rate of PNA had dropped to 12.5% instead of the 29.5% prior to 
any intervention beginning.  This change might possibly be due the organization knowing 
there was a problem.  After the NP and the organization were aware they were being 





Framework of the Organization’s Strategic Plan  
 
 The contribution of this PNA project was improvement in the overall rate of PNA 
in patients with a prescription for a bisphosphonate organization-wide.  This protocol 
implementation improved the quality of care being delivered and might have saved 
money.  The outcomes of this study have shown the importance of increasing the 
patient’s involvement as a team member in this process.  Obtaining their feedback was 
invaluable in closing the gap and improving systems to meet organizational goals.  
Communication between the patient and the provider can continue to be improved and 
the communication path should begin as early as the day the prescription was written.  A 
verbal contract prior to the prescription being written and verbal acknowledgement that 
the patient accepts the prescription being written and is aware of it being sent to the 
pharmacy are important steps that should be added to every patient encounter.  The 
patient must be informed early in the process so he/she can be prepared for what is 
expected of him/her.  Secondly, a component that should be added is more DXA scan 
orders and more diagnoses of osteoporosis or low bone mass so patients can be risk 
stratified and counselled.  This process of risk stratification could spark a communication 
between the provider and the patient and stress the importance of taking the prescribed 
medication.  These are teaching moments, especially if the patient has already suffered a 
fracture and been told how a second fracture could be prevented.  Enhanced 
communication and acceptance of the protocol or achieving “buy in” from the patient 
could surely improve patient adherence to his/her prescribed medications. 
 This telephone protocol worked well within the organization’s strategic plan 
because it used a protocol telephone outreach that was simple and easy to implement. 
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This was evidenced by having only one NP manage calls within the program.  Human 
interaction might be potentially replaced by a computer to call and leave automated 
messages.  Since many of the patients in the study picked up the medication after 
receiving only a message, it might still be effective to leave an automated message.  
Patients who wish to speak to a person can opt to leave a message to have someone return 
their call.  
 The telephone outreach approach to closing a PNA care gap could cut down on 
the amount of time and staff needed to add face-to-face visits that could be replaced by a 
phone call.  The telephone encounter was believed to lead to cost savings because it was 
carried out by a single NP and used minimal staff time.  Although, the actual amount of 
time or cost savings was not measured, this needs further study.  The results of this study 
suggested a telephone message might be just as effective as a telephone conversation as 
the average amount of time needed to pick up medication after a telephone call was 2.5 
days.  Twenty-seven out of 216 patients needed one or more calls.  Many of the 20 
adherent patients picked up their medication after receiving only a reminder message.  
Using a computer instead of a staff person for reminder calls could results in cost savings 
provided it was effective.  A telephone call could replace clinic time to answer questions 
or to follow up on monitoring care or treatments.  Since telephone outreach is already a 
function of the NP’s normal duties as a care manager, this protocol could be easily 
worked into the daily activities of a disease management program coordinator’s duties.  
This work as done by NP care managers or possibly a computer could easily be 
assimilated into any chronic disease management program to improve outcomes.  
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 Results not having statistical significance in this study were shown to have 
clinical significance and vice versa.  For example, two patients picked up the medication 
prior to receiving a call.  This result had no clinical significance because although they 
were not influenced by the call, they went past 14 days and so they were counted in the 
call group.  Therefore, although they appeared to be PNA, they actually had intention of 
picking up the medication and did so without the need for coaching by the NP. 
 In this study, the NP answered the same on the questionnaire before and after the 
implementation of the study.  There might have been more opportunity to focus on how 
the NP could have augmented conversations with patients to use the TPB more 
effectively as it was intended to change patient behavior. 
Contribution of the Project to the Attainment 
of Personal Leadership Goals 
 
 This project was a very important research study in the attainment of the 
researcher’s personal goals. This project addressed an interest in practicing in the area of 
population disease management, identifying care gaps, and then working to develop 
clinical practice guidelines to close those care gaps.  Primary non- adherence (PNA) in 
the field of osteoporosis disease management is a huge problem that has prevented the 
program from attaining its goals and improving patient outcomes.  The study results 
showed this telephone outreach program worked in one system might also be 
implemented in other programs with high non adherence rates.  Chronic diseases such as 
diabetes and hypertension have no symptoms until the diseases have progressed to 
dangerous levels.  Patients with asymptomatic chronic diseases such as osteoporosis have 
a high risk of PNA.  Until the fracture event occurs, many patients do not understand the 
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importance of prevention.  Medication in this case could prevent fracture from occurring 
50% of the time.   
 Disease management programs rely heavily on patients taking their medication in 
order to prevent the progression of their disease but to date no interventions have 
monitored whether or not patients were actually picking up their medication from the 
pharmacy and taking it as prescribed.  It is extremely rewarding as a healthcare provider 
to see patients getting better and to prevent the progression of disease, morbidity, and 
mortality.  If outcomes in disease management are to be improved, it is important to 
understand the patient from his/her viewpoint and include them as a member of the 
healthcare team.  This study and protocol were intended to include the patient as a team 
member and to use communication and feedback to find out the reasons patients did not 
take their medication and then intervene appropriately.  Historically, this happened 30% 
of the time; now it has been shown to be less than 5% and hopefully in the future, it can 
be reduced to zero. 
How the Project Compares to the Solution 
 
 The study goals/objectives were reached as expected quite expediently once the 
NP had a protocol and understood the task at hand.  The patients who were contacted 
were very cooperative.  Only a small amount of patients could not be reached or 
continued to choose non-adherence despite the multiple attempts by the NP to talk to 
them.  The project appeared to fit the solution needed.  This was evidenced by the 
significant decrease in the PNA rate reported.  There was an 89.2% decrease in relative 
reduction in PNA from the historic PNA rate and the current rate retrieved from the 
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study.  The chi square for the significance of this occurrence was p < .0001, which means 
the reduction seen in this study could not have been by chance. 
Summary 
 It has been two years since the Reynolds et al. (2013) article was published and 
the implementation of the telephone outreach solution tool.  Acknowledging a problem 
and implementing a protocol as a different way of talking to patients or prescribing might 
have led to an unconscious improvement in the rate of PNA prior to the study because the 
staff knew what was expected of them and the NP knew her actions were being 
monitored.  This was reflected in the NP questionnaire when she received the same score 
on both pre- and post-tests, showing she already had a strong belief in PNA and the 
implementation of the study.  Her beliefs did not change or improve after the 
implantation of the study and remained strong and in full support throughout. 
 The literature has shown that having a dedicated NP coordinator could reduce the 
hip fracture rate and improve outcomes.  Using a telephone outreach program, patient and 
provider communication would be enhanced and this could translate into better 
medication adherence.  Waalen et al. (2009) indicated an FLS program using a telephone 
outreach protocol to improve medication adherence was slightly better than the general 
population.  Furthermore, Eisman et al. (2012) determined that having a dedicated 
coordinator communicate and coordinate fracture care and treatment translated to cost 
savings.  A telephone outreach might augment an existing the FLS program to improve 
adherence to bisphosphonate medication and enhance communication essential to 
improved adherence.  This study documented a problem of PNA and used an FLS 
program NP and a systems-based approach to close the care gap.  It is hoped this study 
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could be conducted on a larger scale to further investigate this aspect of the FLS program, 
determine the benefits of implementing a telephone outreach protocol based on the 
theoretical principle of self-efficacy and TPB, and see whether medication adherence 
would improve outcomes and save time and money.  Additionally, an automated 
telephone outreach systems could free up the coordinator’s time even further to 
effectively automate calls to remind patients and let them know an action to pick up their 
medication from the pharmacy was expected, thereby increasing opportunities to improve 
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The purpose of this questionnaire is to elicit feedback from the NP regarding her 
understanding that there is a problem of PNA before and after her in-service and to gauge 
her beliefs of the possibility of arriving at a solution to PNA by using the protocol.  You 
are being asked to rank your responses on a scale of 1-6 of your beliefs before and after 
the study.  Please circle your response and sign the bottom. 
1. How much of a problem do you believe PNA poses in your patient population? 
 
  Please circle 1--no relationship to 6--extreme positive relationship 
 
Before 1 2 3 4 5 6 
After 1 2 3 4 5 6 
 
2. Do you believe you can play a role to improve the rate of PNA using the  
 protocol? 
Please circle 1--no relationship to 6--extreme positive relationship 
 
Before 1 2 3 4 5 6 
After 1 2 3 4 5 6 
 
3. How important of a role does patient input play in the process of improving PNA? 
 Please circle 1--no relationship to 6--extreme positive relationship 
Before 1 2 3 4 5 6 
After 1 2 3 4 5 6 
 
4. Do you believe you understand what is PNA? 
 Please circle 1--no relationship to 6--extreme positive relationship 
Before 1 2 3 4 5 6 





Normative/Subjective Belief  
 An individual's perception about the particular behavior is influenced somewhat 
by the judgment of significant others.  The individual NP’s perception of social 
normative pressures and relevant others' beliefs that he or she should or should not 
perform such behavior.  In this case normative behavior will be affected by what the NP 
believes her peers will think of her and what is in her scope as an NP.  Behavior that is 
influenced by the judgment of significant others or others with influence or others such as 
managers.  Such as in this case, the NP is influenced by the telephone protocol steps and 
the desires of her manager to implement the protocol. 
 
5.  What are your beliefs about your normative/subjective belief in this study? 
  Please rank that you are influenced by what is expected of you by others. 
 Please circle 1 = no influence to 6 = extreme influence 
 
Before 1 2 3 4 5 6 
After 1 2 3 4 5 6 
 
Control Beliefs /Perceived Behavioral Control 
 An individual's perceived ease or difficulty of performing the particular behavior 
(Ajzen, 1991).  It is assumed that perceived behavioral control is determined by the total 
set of accessible control beliefs.  In this case, the NP needs to believe she has control of 






6. What are your beliefs about your behavioral control beliefs in this study? 
Please circle 1 = no influence to 6 = extreme influence 
Before 1 2 3 4 5 6 





Below is an evaluation checklist to be done by the DNP student for each patient enrolled 
in the study and contacted by the NP. 
NP Evaluation Checklist 
NP Evaluation form date 14 days 30 days 45 days 60 days Comments 
Provider--who wrote the 
prescription 
     
Name of patient      
Medical Record #      
Comments made by Care 
Manager 
     
Sex      
Age      
Medication      
Date Ordered      
Last DXA      
Tscore      
Hx AFF (Exclude if yes)      
Last FX      
Last FX Date      
LTC/SNF/Hospice  (Exclude 
if yes) 
     
Allergy  (Exclude if allergy 
BP) 
     
Last CKD (Exclude if CKD 
4,5 or Dialysis) 
     
Last CKD Date      
Dx Exclusion      
Dx ExclusionDate      
Reclast Date (Exclude if last 
Reclast  within 1 year) 
     
Home Phone      
Work Phone      
Med Center      
Meds written to pick up 
outside Kaiser - excluded 






Patient Evaluation of Responses During Telephone Outreach 
Question Domain of Adherence Theory of Planned 
Behavior 
Patient Responses 
The system shows that you have 
not picked up your anti-
osteoporosis medication from the 
pharmacy. Are you aware of this 
prescription? 
Knowledge  Yes/no 
Is there a reason you did not pick 
up the medication? 
Attitude  Yes/no 
If yes state reason 
Do you believe that you need this 
medication? 
 
Attitude  Yes/no 
 
Are you satisfied with your doctor 
visit experience and the 
instructions given to you about the 
medication? 





Do you have family and other 
support to help you with bone 
health issues? 
Social support Social Yes/no 
 
 
Taking medications regularly is a 
hassle to some people. Do you 
feel that taking your medication is 
too inconvenient or too complex? 
 
Medication complexity Subjective Yes/ no  
 
 
Do you have concerns such as 
fear of taking this specific 
medication? 
If yes state the fear. 
 
Stress Perceived Control Yes/no 
 
  
Do you sometimes feel like you 
don’t want to take your 
medication because you don’t 
believe that you  
 
Coping Subjective Yes/ no 
 
 
Do you plan to pick up the within 
the next week?  
Developing intention Control Yes/no 
 
Was this call instrumental in 
helping you to decide to pick up 
your medication? 
Developing intention  Yes/no 
 
 
Was this call helpful in answering 
all of your questions? 
























Telephone Outreach Protocol 
Do you give me consent to ask you questions about your prescription medication? 
 Questions Yes/No 
1).The system shows that you have not picked up your anti-
osteoporosis medication from the pharmacy. Are you aware of this 
prescription? Level of intention to pick up 
 
2)Is there a reason that you did not pick up the medication? State the reason  
3) Do you believe that you need this medication? 
 
 
4).Are you satisfied with your doctor visit experience and instructions given 
to you about the medication 
 
5Do you have family or other support to help you with bone health issues?  
6) Taking medications regularly is a hassle to some people. Do you feel that 
taking medication is too inconvenient or complex? 
 
7) Do you have concerns such as fear of taking this specific medication?  
8) Do you sometimes feel like you don’t want to take your medication 
because you don’t believe you need  it? 
 
9). Do you plan to pick up the medication within the next week?  
10). Was this call instrumental in helping you to develop a new intention to 
pick up the medication? 
 






















Dear Ms. Test Patient,  
This past week you were diagnosed with osteoporosis, which means you are at 
an increased risk for having a fracture or broken bone with a simple fall or 
minor accident.  As I reviewed your health records, I noticed you have not filled 
your prescription to treat your osteoporosis with Alendronate.  This medication 
reverses bone loss, strengthens bones, and prevents fractures and is usually 
taken for at least five years. 
Please fill this prescription as soon as possible.  When your prescription runs 
out, you may request a refill by calling the pharmacy.  If you have any concerns 
regarding treatment with this medication or if you have any questions 
regarding your osteoporosis, please do not hesitate to call me. 
Sincerely, 
 

































Date of Rx______________________________ 
 
Date of call____________________________ 
 
 
Sequence in the process/protocol of calls : 
Circle one : 
 
14 day,  
30 day,  
45 day,  
 
60+ days since patient has picked up medication 
 
 
Did call go to voicemail?  Y   /   N   
Left message to call back  Y /  N 
 
















Summary of Patient Responses 
Patient Population Adherent % PNA% Pvalue= 
N=216 N= N=  
Independent 
variable 
Number Adherent Number PNA Pvalue= 
Age    
55-64    
65-74    
75-84    
85+    
Sex=Men    
Sex= Women    
Characteristics of 
Prescriber 
   
NP    
MD    
Other    
 
